Only for premium:
Start your 14-day free trial
| Download example PDF report
You have 3 of 3 checks left today.
Show your SEO score to your visitors using the Seobility widget. The widget always displays the current SEO score of your homepage.
Name | Value |
---|---|
generator | TYPO3 CMS |
description | Vienna BioCenter offers a unique combination of research, education and companies. Leader in life sciences. Find out about our campus, our jobs and more! |
viewport | width=device-width, initial-scale=1 |
robots | index,follow |
notranslate | |
apple-mobile-web-app-capable | no |
msapplication-TileColor | #da532c |
theme-color | #ffffff |
lang | en |
twitter:card | summary |
twitter:description | Work at one of Europe's hotspots for life sciences! |
twitter:title | VBC |
og:title | Vienna Bio Center |
og:description | Work at one of Europe's hotspots for life sciences! |
og:image | https://www.viennabiocenter.org/fileadmin/user_upload/VBC/Homepage/Carousel_train.jpg |
og:image:url | https://www.viennabiocenter.org/fileadmin/user_upload/VBC/Homepage/Carousel_train.jpg |
og:image:width | 1600 |
og:image:height | 510 |
og:type | website |
og:url | https://www.viennabiocenter.org/ |
charset | utf-8 |
Video URL | Width | Height |
---|---|---|
...oad/VBC/News/Berger_NatCellBio202104.mp4 | 282 | 159 |
...admin/user_upload/VBC/News/Fischli2a.mp4 | 282 | 159 |
Heading level | Content |
---|---|
H2 | Vienna BioCenter - Top Life Science Cluster |
H2 | Facts and Figures |
H2 | Education and Career |
H2 | Six Research Institutions |
H2 | Key Discoveries |
H2 | HUMAN BRAIN ORGANOIDS |
H2 | HUMAN BRAIN ORGANOIDS Duplicate text |
H2 | CRISPR/Cas9 |
H2 | CRISPR/Cas9 Duplicate text |
H2 | MECHANISMS OF CHROMOSOME SEGREGATION |
H2 | MECHANISMS OF CHROMOSOME SEGREGATION Duplicate text |
H2 | EPIGENETICS |
H2 | EPIGENETICS Duplicate text |
H2 | 1001 GENOMES |
H2 | 1001 GENOMES Duplicate text |
H2 | Key Events |
H2 | News |
H2 | Empty heading |
H2 | Cookies |
H3 | You shall not pass |
H3 | Survival of the filamentous |
H3 | All Eyes on the Proteome |
H3 | Unrecyclable: how protein aggregates evade clearance |
H3 | Otto Hahn Medal and Award for Ida Jentoft |
H3 | New Perutz Principal Investigator Projects funded by FWF |
H3 | Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases |
H3 | Jacob Schreiber to join IMP faculty as visiting scientist |
H3 | Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine |
H3 | Joris van der Veeken secures FWF funding |
H3 | IMP Emeritus Director Barry Dickson elected Fellow of the Royal Society |
H3 | Bernardo de Almeida wins 2024 Denise P. Barlow Award |
H3 | Nature’s 3D Printer: Bristle Edition |
H3 | Time is of the essence |
H3 | Filip Nemcko among Forbes Slovakia “30 Under 30” |
H3 | Revving up the engine: Immunity on Standby |
H3 | HFSP grant for consortium led by Kristin Tessmar-Raible |
H3 | Clemens Plaschka elected to ÖAW Young Academy |
H3 | Perutz group leaders receive individual funding from FWF |
H3 | Don’t judge a book by its cover |
H3 | 5 ERC Grants Awarded to Vienna BioCenter Scientists |
H3 | HFSP Fellowship for IMP postdoc Vytaute Boreikaite |
H3 | Seeing the unseeable |
H3 | FWF and ÖAW award “Disruptive Innovation Grant” to Johannes Schmoellerl (IMP) |
H3 | Mass Spec-tacular: Proteomics at the Perutz |
H3 | IMBA Welcomes Elly Tanaka as Scientific Director |
H3 | FWF Emerging Fields grant for search of immunotherapy against childhood cancer |
H3 | "Heart" of the spliceosome: putting together a molecular machine |
H3 | Marie Skłodowska-Curie fellowship for Rupert Faraway to study mRNA selection mechanism |
H3 | Three GMI scientists awarded Marie Skłodowska-Curie Postdoctoral Fellowships |
H3 | Researchers at the Vienna BioCenter and in Ghana team up to advance diagnostics in Africa |
H3 | Funding for two interdisciplinary projects to ‘understand biology with artificial intelligence’ |
H3 | Prestigious EMBO Fellowships for two IMP postdocs |
H3 | Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine |
H3 | Sperm's creative approach to genome packing |
H3 | What does cooking have to do with science? - Interview with new group leader Pim Huis in 't Veld |
H3 | How eggs keep their messenger RNAs quiet |
H3 | Decoding genome instability: New doc.funds initiative at the Perutz |
H3 | Artificial Intelligence cracks code of gene regulation |
H3 | New insights into how B cells time the duplication of their genome |
H3 | Alejandro Burga (IMBA) and David Haselbach (IMP) join EMBO Young Investigator Program |
H3 | The stage is yours, DIDO! |
H3 | First multi-chamber heart organoids unravel human heart development and disease |
H3 | Decoding cell fate: Key mechanism in stem cell switch identified |
H3 | Nine “Highly Cited Researchers” at Vienna BioCenter in 2023 |
H3 | New Max Perutz PhD fellows |
H3 | Phosphatase loss spells problems for the prostate |
H3 | Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, IXCHIQ® |
H3 | AVINA Grant for CeMESS group leader Shaul Pollak |
H3 | Why TOFU is good for worms |
H3 | The last stand - Plant stem cells put up a fight against viruses |
H3 | International Birnstiel Award 2023 celebrates six outstanding scientists |
H3 | Scientists show how cells build protein destruction signals |
H3 | Immunologists reveal how the Pax5 protein regulates B cell development and commitment |
H3 | CHOOSEn fate: one brain organoid’s tale on Autism |
H3 | Goldilocks and the E3 ligase |
H3 | Unearthing the hidden trove of long non-coding RNAs in plants |
H3 | Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate |
H3 | Broadcasting DNA using transposons: ERC Starting Grant for Irma Querques |
H3 | Network-based approaches open a new avenue to classify and treat rare diseases |
H3 | Prestigious fellowships awarded to Max Perutz Labs PhD students |
H3 | Lipid Chemistry Empowers Nuclear Shape |
H3 | 2.5M euros funding for single-cell proteomics |
H3 | 20th Vienna BioCenter PhD Symposium: 9/10 November 2023 |
H3 | "In science, you can’t get bored" - Interview with new group leader Irma Querques |
H3 | A CRISPR-based lab tool for lineage tracing in vivo |
H3 | HiCognition: A computational tool to navigate the genome in 3D |
H3 | FWF awards ESPRIT grant to study single-cell proteomics of human blastoid |
H3 | A cohesin-regulated tug-of-war inside chromosomes |
H3 | IMP Senior Group Leader Anna Obenauf elected EMBO Member |
H3 | Virus-like transposons wage war on the species barrier |
H3 | How land plants regulate tissue development and organogenesis |
H3 | START grant for Stephanie Ellis |
H3 | Many roads lead to Rome |
H3 | 3 new FWF grants awarded to Max Perutz Labs scientists |
H3 | Dissecting the forces that govern epigenetic memory |
H3 | IMP's Elly Tanaka elected to National Academy of Sciences |
H3 | HFSP grant awarded to Kristina Djinovic and Jonas Ries |
H3 | Elucidating the mechanism behind the medicine |
H3 | Yasin Dagdas elected to the OeAW’s Young Academy |
H3 | Muscle health depends on lipid synthesis |
H3 | FWF approves Cluster of Excellence with CeMESS lead |
H3 | Alfred Hauptmann Prize for research on Tuberous Sclerosis at IMBA |
H3 | Traffic jam: gene transcription hampers cohesin’s travel along chromosomes |
H3 | Win some – lose some: how cells adapt to aneuploidy |
H3 | The dual face of photoreceptors during seed germination |
H3 | Egon Macher Award for Lukas Leiendecker |
H3 | Learning from viruses |
H3 | Embryos gaining independence |
H3 | Valneva Completes Enrollment for Adolescent Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate |
H3 | Autophagy: The molecular regulation of self-eating |
H3 | Do it yourself – kinase activation revisited |
H3 | "Guardian of the Cell": structure and key function of giant protein explained |
H3 | A tale of DNA loops: how distant DNA segments come together to make different types of antibodies |
H3 | Stressing out the immune system |
H3 | SNSF fellowship for postdoc Milica Vulin |
H3 | Bryophytes branch differently... also at the molecular level |
H3 | Switch it off: new insights into repressors of gene transcription |
H3 | Coping with chromosomal stress |
H3 | Portrait of a protein family |
H3 | Weiss-Kruszka syndrome and the failure to establish neuronal identity |
H3 | Punching holes in the nucleus |
H3 | FWF awards doc.funds and stand alone project grants |
H3 | Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate |
H3 | Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate |
H3 | Sebastian Falk joins EMBO Young Investigator program |
H3 | Awakening the genome |
H3 | ERC Starting Grants for Joanna Jachowicz and Kelly Swarts |
H3 | Revealing the architectural secrets inside mini-organs |
H3 | Max on the wall |
H3 | Awards of the Vienna BioCenter PhD Symposium 2022 |
H3 | HUSHing repetitive-like elements contributes to normal brain development and function |
H3 | FWF grants awarded to Max Perutz Labs scientists |
H3 | New stop along the cellular journey of recycling organelles in plants |
H3 | Old drugs new tricks |
H3 | Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences |
H3 | “Kipferl”: Guiding the defense against jumping genes |
H3 | New light for electron microscopy |
H3 | Circalunar clocks: using the right light |
H3 | Breaking down proteins: How starving cancer cells switch food sources |
H3 | Stephanie Ellis named a 2022 Vallee Scholar |
H3 | Old drugs hint at new ways to beat chronic pain |
H3 | Conversing with the past: how evolution shaped the human mind |
H3 | Where art and science meet |
H3 | When mothers shut down the fathers’ genes in the embryo |
H3 | Transcription factor PAX5 linked to antibody deficiency and brain development |
H3 | Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 |
H3 | How the genome is packed into chromosomes that can be faithfully moved during cell division |
H3 | Receptor FIBCD1 newly identified in neuro-developmental disorders |
H3 | AAAS Wachtel Cancer Research Award 2022 for Anna Obenauf (IMP) |
H3 | On standby: how the developing embryo guards against viral infection |
H3 | The axolotl, a new model to improve the healing of broken bones |
H3 | The beginning of life: The early embryo is in the driver's seat |
H3 | Johannes Zuber elected EMBO Member |
H3 | CEBINA publishes data demonstrating the anti-histamine azelastine inhibits infection by major variants of SARS-CoV-2 |
H3 | “The idea is to connect people” - Manuela Baccarini elected Vice-Rector of the University of Vienna |
H3 | Exhibition about Max Perutz draws over 5.000 visitors |
H3 | “Cherish the beginning” - Interview with new group leader Stephanie Ellis |
H3 | Climate@MaxPerutzLabs initiative wins Austrian Sustainability Award 2022 |
H3 | Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001 |
H3 | Anna Obenauf and Andrea Pauli promoted to Senior Scientists |
H3 | Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15 |
H3 | ÖAW DOC Fellowships awarded to Max Perutz Labs students |
H3 | Tracking cells in the regenerating limb through space and time |
H3 | BacPROTACs: antibiotics of the future |
H3 | Putting a finger on meiosis |
H3 | Milestone in understanding regulation of gene transcription |
H3 | Rendezvous at night – how moonlight fine-tunes animal reproduction |
H3 | Undergraduate student fits one more piece to the regeneration puzzle |
H3 | ERC Proof of Concept to investigate clinical applications of blastoids |
H3 | Anna Obenauf part of international consortium to study bone cancer |
H3 | Diana Pinheiro to establish research group at IMP |
H3 | An open-source COVID-19 test empowers African diagnostics and research |
H3 | Austrian Science Fund supports heart regeneration research for next four years |
H3 | EMA accepts filing of marketing authorization application for Valneva’s inactivated COVID-19 Vaccine Candidate |
H3 | IMP Postdoc Paul Murphy joins the ESPRIT Programme |
H3 | EMBO Fellowship for IMP postdoc Franziska Lorbeer |
H3 | Harnessing artificial intelligence to predict and control gene regulation |
H3 | Science for Resilience: Conference at Vienna BioCenter to discuss outlooks on Covid-19 |
H3 | Alwin Köhler elected corresponding member of the Austrian Academy of Sciences |
H3 | City of Vienna Prize presented to Meinrad Busslinger and Jürgen Knoblich |
H3 | IMP scientists solve first plant proteasome structure with supermarket spinach |
H3 | #ScienceChatIMBA: Double agents - How stomach stem cells change allegiance upon injury |
H3 | Austrian Academy of Sciences honours Elly Tanaka with full membership |
H3 | Squid genome sheds light on extraordinary brain evolution |
H3 | F.-Ulrich Hartl to give Max Birnstiel Lecture |
H3 | DNA loop formation linked to Cornelia de Lange Syndrome |
H3 | Scientists discover essential role of two proteins for fertilisation |
H3 | Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate |
H3 | MSCA Postdoc Fellowship for Elias Adriaenssens |
H3 | Valneva Receives Conditional Marketing Authorization from UK MHRA for its Inactivated COVID-19 Vaccine |
H3 | New lessons from an old master |
H3 | FWF Stand-Alone grants awarded to Max Perutz Labs scientists |
H3 | Minister of Education, Science and Research visits Vienna BioCenter |
H3 | ERC Consolidator Grants for Andrea Pauli and Yasin Dagdas |
H3 | Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate |
H3 | Max Perutz PhD Fellowships awarded |
H3 | Cell fate determination: making sense out of nonsense |
H3 | Ignaz Lieben Prize awarded to Kristin Tessmar-Raible |
H3 | Resistance and tolerance: two sides of the same coin |
H3 | Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA2001 |
H3 | Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 |
H3 | Peter Schlögelhofer promoted to University Professor |
H3 | Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development |
H3 | Keeping meiotic entry in check |
H3 | How a small RNA pathway talks to the heterochromatin machinery |
H3 | Aiming for the basket |
H3 | Moritz Gaidt to study innate immunology at IMP |
H3 | ERC grant for Thomas Juffmann |
H3 | Blooming too soon: timing is crucial to error-free cell division |
H3 | Stay positive – how the brain incites mice to react positively to both fear and reward |
H3 | Not all brains are equal: Why the human brain is more vulnerable to disease |
H3 | Of inclusive science and exceptional mentoring: science communication award for Victoria Deneke |
H3 | IMP students characterise a sperm protein essential for zebrafish fertilisation |
H3 | New funding for meiosis research |
H3 | Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant |
H3 | Bhlhe40, a molecular gatekeeper that prevents the formation of lymphomas |
H3 | Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001 |
H3 | Tim Clausen and collaborators secure two prestigious grants |
H3 | CEBINA reports broad anti-viral potency of azelastine has potential for use against influenza and RSV infections in addition to SARS-CoV-2 and its variants of concern including the Omicron variant |
H3 | Anna Obenauf and Clemens Plaschka elected EMBO Young Investigators |
H3 | Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy |
H3 | PhagoMed becomes BioNTech R&D (Austria) |
H3 | Breakthrough research on human blastoids and impact on IVF and contraception |
H3 | Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine Program VLA2001 |
H3 | Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001 |
H3 | Prestigious prize of the Austrian Society of Allergology and Immunology for Louisa Hill |
H3 | Anete Romanauska wins Science & SciLifeLab Prize |
H3 | CRY2, a component of the bird internal clock |
H3 | Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001 |
H3 | ‘Network medicine’ directs disease diagnosis |
H3 | Melanie de Almeida wins the Lauwers Award |
H3 | Decoding the role of PHF3 in transcription |
H3 | Vienna BioCenter PhD Awards 2021 for two IMP and two IMBA graduates |
H3 | How cells keep their nucleus clean: a fundamental discovery |
H3 | Ares Genetics launches AREScloud for the analysis of sequenced clinical isolates |
H3 | FWF grants awarded to Max Perutz Labs researchers |
H3 | Prestigious grants for Rushad Pavri and Wouter Masselink |
H3 | Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 |
H3 | miR-1: an ancient molecule controls muscle physiology |
H3 | Louisa Hill wins the Rabitsch Award 2021 |
H3 | Mission possible: how cohesin fits two meters of DNA into a human cell |
H3 | International Birnstiel Award 2021 for six outstanding young scientists |
H3 | “Always try to disprove your results” |
H3 | Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate |
H3 | How to detox the nucleus of unsaturated fat |
H3 | Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 Vaccine |
H3 | “This is one of the best times to do science” |
H3 | Federal Minister of Health Wolfgang Mückstein visits Vienna BioCenter |
H3 | Close friends and distant relatives |
H3 | Valneva Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine |
H3 | Vienna BioCenter Summer School welcomes 15 students from around the world |
H3 | PETISCO - a multi-tool for piRNA processing |
H3 | Proteus changes his Akt |
H3 | Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate |
H3 | "Tardigrades take the stage" - Adrià Nogales Moral about his research topic and scientific outreach |
H3 | Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate |
H3 | Vienna BioCenter researchers hone method for low-cost mass analysis of SARS-CoV-2 mutations |
H3 | The Embassy of the State of Israel visits the Vienna BioCenter |
H3 | An internship program for Salvadoran students at the IMP |
H3 | Signal transduction: In the right place, at the right time |
H3 | Cross-resistance: when cancer therapy backfires |
H3 | Valneva Awarded FDA Breakthrough Designation for its Single-Shot Chikungunya Vaccine Candidate |
H3 | Boehringer Ingelheim awards the Grass Roots Innovation Prize to a:head bio AG |
H3 | Valneva to Host Symposium on COVID-19 and Chikungunya Vaccine Candidates at 31st European Congress of Clinical Microbiology & Infectious Diseases |
H3 | Hitting the right note in dialysis care |
H3 | Max Perutz PhD Fellowships |
H3 | Profiling gene expression in plant embryos one nucleus at a time |
H3 | Hot off the press: a new role for histone modifications in genomic imprinting |
H3 | ÖAW DOC Fellowships for Max Perutz Labs students |
H3 | CEBINA announces the launch of Danube Labs |
H3 | Amygdala: a piece in the puzzle of pain |
H3 | Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate |
H3 | Meiosis: Mind the gap |
H3 | Disrupting ribosome production – renewed potential for cancer therapy |
H3 | Two Max Perutz Labs scientists elected as EMBO members |
H3 | Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate |
H3 | Colouring tumours reveals their bad influence |
H3 | Building muscles from liquids – phase separation in the Z-disc |
H3 | Biology in the holodeck: exploring cellular interactions with virtual reality |
H3 | Harnessing Next Generation Sequencing to detect SARS-CoV-2 and prepare for the next pandemic |
H3 | Valneva to Participate in the World’s First COVID-19 Vaccine Booster Trial in the UK |
H3 | IMP scientists put limb regeneration under the lens |
H3 | International Birnstiel Award opens 2021 call |
H3 | Anete Romanauska receives Denise P. Barlow Award |
H3 | Valneva Announces the Pricing of its Initial Public Offering on Nasdaq |
H3 | A protein bodyguard – private security in the defense against oxidation |
H3 | Two ERC Advanced Grants for research at Vienna BioCenter |
H3 | Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001 |
H3 | Keeping oocytes fit with Topoisomerase-3 |
H3 | Flowering rooted in embryonic gene-regulation |
H3 | From Bench to Bedside - Molecular Pathogenesis to Precision Medicine |
H3 | Valneva Completes Recruitment for Pivotal Phase 3 Trial of Chikungunya Vaccine Candidate and Initiates Antibody Persistence Trial |
H3 | Brain organoids uncover various mechanisms of virus-induced microcephaly |
H3 | Lockdown for genome parasites |
H3 | Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001 |
H3 | No centrioles? No problem! |
H3 | Tiny droplets – huge impact: FWF doc.funds grant on liquid-liquid phase separation |
H3 | Hidden in plain sight: A-type lamins in the nucleus |
H3 | When synthetic evolution rhymes with natural diversity |
H3 | Living in a gated community – how stem cells preserve their identity |
H3 | Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate |
H3 | Valneva Reports FY 2020 Results and Major Corporate Achievements |
H3 | Valneva Initiates Phase 3 Clinical Lot Consistency Study for its Single-Shot Chikungunya Vaccine Candidate |
H3 | Tearing down walls for a new beginning |
H3 | Silencing by crosstalk |
H3 | Shedding new light on an old problem |
H3 | “Basic research and teaching should go hand-in-hand” |
H3 | Valneva Announces UK Government Exercise of Option for 40 Million Doses of its Inactivated, Adjuvanted COVID-19 Vaccine |
H3 | Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment |
H3 | Biolution proudly presents its new demo reel |
H3 | Valneva and Instituto Butantan Sign Final Agreement on Single-Shot Chikungunya Vaccine for Low and Middle Income Countries |
H3 | Strength in numbers: how weak enhancers can be powerful gene regulators |
H3 | Revealing the genetic code of ribosomal RNAs |
H3 | Valneva in Advanced Discussions with European Commission to Supply up to 60 Million Doses of Inactivated, Adjuvanted COVID-19 Vaccine Candidate |
H3 | More than just a sun tan: ultraviolet light helps marine animals to tell the time of year |
H3 | Valneva Strengthens Management Team; Appoints Perry Celentano as Interim COO and David Lawrence as Acting CFO |
H3 | Selfish elements turn embryos into a battlefield |
H3 | Valneva Reports FY 2020 Cash of Over €200 Million |
H3 | SMICH Doctoral Program receives funding by FWF |
H3 | Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate |
H3 | IMBA Group Leader Nicolas Rivron secures prestigious ERC Grant |
H3 | Exploring the molecular basis of heredity: ERC grant for Joao Matos |
H3 | Leading supercomputer cluster starts operations at Vienna BioCenter |
H3 | Valneva Announces Plans for Extraordinary General Meeting to Prepare for Potential US IPO |
H3 | The testing technology of the future: 36,000 samples in one night |
H3 | Valneva Reports Nine Month Results Marked by Further Major Corporate Achievements |
H3 | A groundbreaking genetic screening tool for human organoids |
H3 | PCR alternative: RT-LAMP, a new SARS-CoV-2 test "Made in Vienna" |
H3 | Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation |
H3 | “No service!” How vaccinia virus jams immune signaling |
H3 | Congratulations to Emmanuelle Charpentier on the Nobel Prize for Chemistry |
H3 | OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud |
H3 | What is the origin of the genetic code? |
H3 | Unraveling the genome in 3D-space |
H3 | Vienna Covid-19 Detection Initiative (VCDI): a response to Covid-19 from the Vienna BioCenter |
H3 | Valneva Announces Retirement of Chief Financial Officer David Lawrence |
H3 | Investigating Parkinson’s through the lens of autophagy - ASAP grant for Sascha Martens |
H3 | The Wnt pathway gets even more complicated |
H3 | Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government |
H3 | City of Vienna honours Meinrad Busslinger |
H3 | Valneva Announces New IXIARO® Supply Contract with the US Government worth up to $166 million |
H3 | Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553 |
H3 | IMBA is lead participant in a new, cell-based medicine initiative for Europe |
H3 | Evomet – a project to train future leaders in metastasis research |
H3 | Autophagy: the beginning of the end |
H3 | ERC Starting Grant awarded to Clemens Plaschka of IMP |
H3 | Cell division: cleaning the nucleus without detergents |
H3 | Calcium causes stiff joints in ɑ-actinin |
H3 | A step towards understanding how animals detect the Earth's magentic field |
H3 | Valneva Reports H1 Results Marked by Major Corporate Achievements and Strong Cash Position |
H3 | Detective work in the cell: Scientists uncover a new RNA-modifying enzyme |
H3 | Startup Labs at the Vienna BioCenter open their doors |
H3 | CaTCH - a molecular time machine for cells |
H3 | Cancer research: Vienna BioCenter start-up breaks new ground in drug discovery |
H3 | Sascha Martens elected EMBO member: “I’m looking forward to helping support young scientists” |
H3 | How the immune system generates a vast antibody repertoire to fight infections |
H3 | Cep97: a stabilizing protein roof for centrioles |
H3 | Researchers develop a "quick and easy" Covid-19 test for population screening with simple means |
H3 | Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership |
H3 | Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine |
H3 | Valneva announces HSR clearance for Lyme vaccine collaboration with Pfizer |
H3 | Valneva Announces Publication in The Lancet of Complete Phase 1 Data for its Single-Shot Chikungunya Vaccine Candidate |
H3 | A “DEEP-Clear” view of nervous system diversity |
H3 | Happy - virtual - birthday, Max Perutz! |
H3 | Jürgen Knoblich now in ISSCR Board of Directors |
H3 | “Reverse engineering” autophagosome biogenesis reveals new protein interactions |
H3 | Scientists discover a gene to stay thin |
H3 | IMP & Birnstiel Foundation open call for 2020 Birnstiel Award |
H3 | How plants forget - new work uncovers how epigenetic marks are specifically reset in sperm |
H3 | Valneva Reports Q1 Results and Updates 2020 Guidance Following Major Lyme Partnering Deal |
H3 | Valneva to Partner with Instituto Butantan on Single-Shot Chikungunya Vaccine for Low- and Middle- Income Countries |
H3 | Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15 |
H3 | Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19 |
H3 | CEBINA joins the global efforts to fight COVID-19 |
H3 | Fighting SARS-CoV-2 in human blood vessel organoids |
H3 | Alwin Köhler appointed as Scientific Director |
H3 | Valneva Reports Positive End-of-Phase 2 Chikungunya Meeting with the U.S. FDA; Sets Stage for Phase 3 Study |
H3 | Valneva Provides Business Update on COVID-19 Situation |
H3 | Layered Liquids – reaction chambers for gene regulation |
H3 | Valneva Announces FDA Approval of IXIARO® Shelf Life Extension to 36 Months; New US Military RFP Issued |
H3 | 7th Ubiquitin Symposium at the Vienna BioCenter |
H3 | CALYXHA endeavors to develop novel approaches to tissue degenerative diseases and receives support from Austrian VC and international investors |
H3 | Mechanism of inactivation of the tumor suppressor PP2A: an illusion shattered by reality |
H3 | VBC PhD student Anete Romanauska wins Harold M. Weintraub Graduate Student Award |
H3 | Valneva Reports Record Product Sales and Major Pipeline Progress in 2019 |
H3 | Fungal pathogens tap human iron stores to survive immunity |
H3 | How bacteria sense and adjust cell envelope precursors |
H3 | FEBS | EMBO Women in Science Award 2020 for IMP's Elly Tanaka |
H3 | Aelian Wins Vienna 5G Use Case Challenge |
H3 | ToxPHACTS available for purchase |
H3 | Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed |
H3 | Curetis Company Ares Genetics and BGI Group to Offer Sequencing and PCRbased Coronavirus (2019-nCoV) Testing in Europe |
H3 | Calibrating the tools of life scientists: Antibodies |
H3 | AFFiRiS announces Phase 2 study in Parkinson's and new focus on neurodegenerative diseases |
H3 | Phenaris launches Transporter Models |
H3 | How decisions unfold in a zebrafish brain |
H3 | Valneva: US DoD Exercises Option on IXIARO® Supply Contract Bringing Total Value to $70 Million |
H3 | Valneva Expands its Commercial Operations with the Opening of its French Commercial Office |
H3 | Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate |
H3 | Valneva Completes Delisting from the Vienna Stock Exchange |
H3 | Moonstruck worms: how lunar cycles affect metabolic decisions |
H3 | Valneva Appoints MVM Partner Thomas Casdagli to its Supervisory Board |
H3 | “ERC-Hattrick” for IMBA Group leader Stefan Ameres |
H3 | Valneva Appoints Renowned Vaccinologists Stanley Plotkin and Anna Durbin to its Scientific Advisory Board |
H3 | Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference |
H3 | Three Special Research Programme grants for Vienna BioCenter scientists |
H3 | A large-scale public event bridging science and society |
H3 | Putting a Lid on Multidrug Resistance |
H3 | Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months |
H3 | Harnessing the power of CRISPR in space and time |
H3 | Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize |
H3 | IMP researchers show that cohesin is a "molecular machine" |
H3 | Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans |
H3 | Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board |
H3 | Vienna BioCenter PhD Awards 2019 |
H3 | Eveliqure's effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries is supported by the Wellcome Trust |
H3 | Limits vs. chances of Biotechnology: A public debate |
H3 | Valneva Raises Product Sales Guidance Following Strong Nine-Month Results and R&D Execution |
H3 | Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test |
H3 | Essential biochemical process driven by alternative cellular fuel discovered |
H3 | a:head signs license and collaboration agreements with IMBA and awarded funding from FFG |
H3 | FOR WOMEN IN SCIENCE - IMBA PhD student receives L'Oréal fellowship |
H3 | Eveliqure's diarrhoea vaccine to advance towards clinical trials supported by significant Horizon2020 award. |
H3 | PhagoMed Accelerates R&D Program Against Bacterial Vaginosis. Phage Lysin Stabilizes Vaginal Microbiome. |
H3 | Four PhD fellowships for Max Perutz Labs students |
H3 | VBC postdoc symposium on publishing models |
H3 | IMP scientists discover a mechanism that controls autoimmunity |
H3 | Anete Romanauska is Researcher of the Month at the Medical University of Vienna |
H3 | It takes two to tango: using the ubiquitin fold to turn on secretion |
H3 | Novel Catalase for complete neutralization of H2O2 in agar plates |
H3 | Valneva Confirms Delisting from the Vienna Stock Exchange |
H3 | IMP and Birnstiel Foundation honour three young scientists with research award |
H3 | Campus Open Day: 11 October 2019 |
H3 | ERC funds to help predict drug responses |
H3 | ERC grant for incoming IMP scientist Francisco Balzarotti |
H3 | Why are small RNA so important? |
H3 | Fighting genomic parasites – lessons from an unusual organism |
H3 | Valneva Announces Management Board Stock Purchases |
H3 | Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing |
H3 | Keeping the genome in shape: a physiological role for NHEJ in meiosis |
H3 | Upcycling of proteins protects DNA from parasites |
H3 | a:head - launched to transform CNS drug discovery |
H3 | "Science is my life" - Interview with Professor Hans Tuppy |
H3 | Valneva Reports H1 2019 Results Marked by Strong Operational Performance and Major Corporate Progress |
H3 | Valneva Announces Formation of Scientific Advisory Board |
H3 | CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine |
H3 | How does a neural stem cell know its age? |
H3 | Valneva Announces Drawdown of Further €10 million from its Existing European Investment Bank Loan |
H3 | HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers |
H3 | Centrioles - critical players in cell division |
H3 | Ares Genetics is granted key European patent on genetic resistance testing |
H3 | Valneva: Renowned Vaccinologist Dr. Stanley Plotkin to Present at R&D Investor Day in New York City on July 9th |
H3 | How cells quickly activate innate immunity |
H3 | SCARLETRED: Patents granted in Japan and Australia |
H3 | Valneva Submits Delisting Application to the Vienna Stock Exchange |
H3 | Valneva Initiates Second Phase 2 Study for its Lyme Disease Vaccine Candidate VLA15 |
H3 | PhagoMed Biopharma GmbH successfully completed another financing round. |
H3 | Valneva Shareholders Approve all Resolutions Recommended by the Management Board at the Annual General Meeting |
H3 | Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D |
H3 | New tool for visualizing molecule properties developed at the Max Perutz Labs |
H3 | “I am excited by the idea that we discover the unknown about the most fundamental things in life.” |
H3 | Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th |
H3 | Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate |
H3 | HOOKIPA Pharma Announces Oral Presentation of HB-101 CMV Vaccine Phase 1 Data at the American Transplant Congress |
H3 | Vienna BioCenter hosts first EMBO Fellow Mini-Symposium |
H3 | First Max Perutz Day kicks off a new era at the Max Perutz Labs Vienna |
H3 | EMBO workshop at the Vienna BioCenter in September to discuss genome organisation by SMC complexes |
H3 | New video tutorial on how to use SLAMseq for profiling transcriptional responses to drugs |
H3 | Phages take center stage in a new animation by biolution |
H3 | An amplified spindle |
H3 | Valneva Reports Further Positive Results for Its Chikungunya Vaccine Candidate |
H3 | First EMBO Fellow symposium at Vienna BioCenter |
H3 | Audio portray on David Haselbach's work on molecular machines |
H3 | Activation of gene promoters: Vienna BioCenter scientists discover basis of regulatory specificity |
H3 | HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead |
H3 | Valneva Reports Strong Q1 2019 Operating Results and Advances Key R&D Programs towards Major Milestones |
H3 | Birnstiel Award: international competition of best PhD students |
H3 | Vienna BioCenter launches "VIP2": a three-year postdoctoral program. |
H3 | Arabidopsis immune system is triggered by small bacterial fatty acids |
H3 | Andreas Bachmair appointed full professor |
H3 | Valneva to Present on Lyme and Chikungunya Vaccine Candidates at the 19th World Vaccine Congress |
H3 | A new type of protein phosphorylation characterised |
H3 | New funding for stem cell research at MFPL and the Vienna BioCenter |
H3 | Student Open Day |
H3 | VBC PhD Programme: Open Call until 15 April 2019 |
H3 | Four new Marie Curie Fellowships at the Vienna BioCenter |
H3 | HOOKIPA Pharma Raises $37.4 million (€33.2 million) in Series D Financing |
H3 | New animation video explains gene expression in unprecedented detail |
H3 | Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019 |
H3 | Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance |
H3 | SY-Stem Symposium at the Vienna BioCenter: 21-23 March 2019. |
H3 | 14th Microsymposium on Small RNA Biology at the Vienna BioCenter: 15-17 May 2019. |
H3 | HOOKIPA Appoints Michael A. Kelly as Independent Director |
H3 | Ubiquitin & Friends 2019: symposium in Vienna |
H3 | Audio portrait of IMP Group Leader Clemens Plaschka |
H3 | Valneva Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate |
H3 | Vienna BioCenter at the ball of sciences |
H3 | 10 Million Euros for Access to European Proteomics Facilities |
H3 | Obituary: Andreas Weith (1953 to 2019), former IMP Group Leader |
H3 | Valneva Announces New $59 Million IXIARO® Supply Contract with US Government |
H3 | Valneva Confirms FY 2018 Guidance and Provides Initial Product Sales Revenue Guidance for 2019 |
H3 | Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate |
H3 | Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test |
H3 | Valneva Announces its Intention to Delist from the Vienna Stock Exchange |
H3 | HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead |
H3 | Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate |
H3 | VBC Summer School 2019 application deadline: 31 January 2019 |
H3 | Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance |
H3 | Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate |
H3 | HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus |
H3 | VIENNA BIOCENTER CORE FACILITIES |
H3 | Analysis / statistics |
Link | Attributes | Anchor text |
---|---|---|
https://www.viennabiocenter.org/ | Anchor | A-TITLE main content |
https://www.viennabiocenter.org/ | A-TITLE VBC Home | |
/career/open-positions/ | Apply A-TITLE Apply | |
/about/contact/ | Contact A-TITLE Contact | |
/research/research-at-vienna-b... | Research | |
/research/research-at-vienna-b... | Research at Vienna BioCenter | |
/research/research-entities/ | Research Entities | |
/research/research-areas/ | Research Areas | |
/research/research-areas/ | Text duplicate | Research Areas |
/research/research-areas/anthr... | Anthropogenic Evolution | |
/research/research-areas/bioch... | Biochemistry, Biophysics, Structure | |
/research/research-areas/cell-... | Cell and Chromosome Biology | |
/research/research-areas/cogni... | Cognitive and Behavioral Biology | |
/research/research-areas/compu... | Computational Biology, Genomes and Evolution | |
/research/research-areas/disea... | Disease Mechanisms, Immunology, Pathogens | |
/research/research-areas/gene-... | Gene Regulation, RNA, Epigenetics | |
/research/research-areas/defau... | Microbiology and Environmental Systems Science | |
/research/research-areas/neuro... | Neurobiology | |
/research/research-areas/plant... | Plant Sciences | |
/research/research-areas/stem-... | Stem Cells, Development, Regeneration | |
/research/research-groups/ | Research Groups | |
/research/key-discoveries/ | Key Discoveries | |
/research/key-discoveries/ | Text duplicate | Key Discoveries |
/research/key-discoveries/cris... | CRISPR/Cas9 | |
/research/key-discoveries/mech... | MECHANISMS OF CHROMOSOME SEGREGATION | |
/research/key-discoveries/huma... | HUMAN BRAIN ORGANOIDS | |
/research/key-discoveries/epig... | EPIGENETICS | |
/research/key-discoveries/1001... | 1001 GENOMES | |
/research/recent-research-high... | Recent Research Highlights | |
/vbcf/ | VBCF | |
/vbcf/austrian-bioimaging/cmi/ | Austrian BioImaging/CMI | |
/vbcf/computational-biology-tr... | Computational Biology Training | |
/vbcf/electron-microscopy/ | Electron Microscopy | |
/vbcf/histology/ | Histology | |
/vbcf/advanced-microscopy/ | Light Microscopy | |
/vbcf/metabolomics/ | Metabolomics | |
/vbcf/next-generation-sequencing/ | Next Generation Sequencing | |
/vbcf/plant-sciences/ | Text duplicate | Plant Sciences |
/vbcf/preclinical-phenotyping/ | Preclinical Phenotyping | |
/vbcf/protein-technologies/ | Protein Technologies | |
/vbcf/proteomics/ | Proteomics | |
/vbcf/vienna-drosophila-resour... | Vienna Drosophila Resource Center | |
/vbcf/child-care-center/ | Child Care Center | |
/vbcf/ | VBCF Landing Page A-TITLE VBCF Landing Page | |
/projects-grants/ | Projects & Grants A-TITLE Projects & Grants | |
/vbcf-jobs/ | VBCF Jobs A-TITLE VBCF Jobs | |
https://my.vbcf.ac.at/ | External Subdomain | My VBCF Info-Hub A-TITLE My VBCF Info-Hub |
/companies/companies-at-vienna... | Companies | |
/companies/companies-at-vienna... | Companies at Vienna BioCenter | |
/companies/biotech-companies/ | Biotech Companies | |
/companies/biotech-companies/ | Text duplicate | Biotech Companies |
/companies/biotech-companies/a... | a:head | |
/companies/biotech-companies/a... | Ablevia Biotech | |
/companies/biotech-companies/a... | ADvantage Therapeutics | |
/companies/biotech-companies/a... | Affiris CVD GmbH | |
/companies/biotech-companies/a... | aitiologic GmbH | |
/companies/biotech-companies/a... | Akribes | |
/companies/biotech-companies/a... | Austrianni | |
/companies/biotech-companies/b... | BioNTech R&D Austria | |
/companies/biotech-companies/b... | Biosynth | |
/companies/biotech-companies/b... | Bird-C | |
/companies/biotech-companies/b... | bit.bio discovery GmbH | |
/companies/biotech-companies/c... | CALYXHA Biotechnologies | |
/companies/biotech-companies/c... | ChanPharm | |
/companies/biotech-companies/e... | Eveliqure | |
/companies/biotech-companies/e... | Evercyte | |
/companies/biotech-companies/e... | Exscientia | |
/companies/biotech-companies/g... | G.ST Antivirals | |
/companies/biotech-companies/h... | HD Immune | |
/companies/biotech-companies/h... | HeartBeat.bio AG | |
/companies/biotech-companies/h... | HOOKIPA Pharma Inc. | |
/companies/biotech-companies/i... | invIOs | |
/companies/biotech-companies/j... | JLP Health | |
/companies/biotech-companies/l... | Lexogen | |
/companies/biotech-companies/m... | Miti Biosystems | |
/companies/biotech-companies/m... | MyeloPro Diagnostics and Research GmbH | |
/companies/biotech-companies/m... | Myllia Biotechnology | |
/companies/biotech-companies/o... | OncoOne | |
/companies/biotech-companies/p... | Pregenerate | |
/companies/biotech-companies/p... | proxygen GmbH | |
/companies/biotech-companies/q... | QUANTRO Therapeutics | |
/companies/biotech-companies/s... | SCARLETRED | |
/companies/biotech-companies/t... | TAmiRNA | |
/companies/biotech-companies/t... | Thermo Fisher Scientific | |
/companies/biotech-companies/t... | THT Biomaterials GmbH | |
/companies/tridem-bioscience/ | Tridem Bioscience | |
/companies/biotech-companies/v... | Valneva | |
/companies/biotech-companies/x... | X4 Pharmaceuticals | |
/companies/biotech-companies/y... | YGION Biomedical GmbH | |
/companies/service-companies/ | Service Companies | |
/companies/service-companies/ | Text duplicate | Service Companies |
/companies/service-companies/b... | Biolution | |
/companies/service-companies/l... | LabConsulting | |
/companies/service-companies/n... | net4biz | |
/companies/service-companies/i... | IG StartUP Solutions GmbH | |
/companies/business-incubators/ | Business Incubators | |
/companies/business-incubators/ | Text duplicate | Business Incubators |
/companies/business-incubators... | CEBINA | |
/companies/business-incubators... | INiTS | |
/education/ | Education | |
/career/open-positions/ | Career | |
/career/open-positions/ | Open Positions | |
https://welcome.vbc.ac.at/ | External Subdomain | Welcome Office |
/career/why-work-here/ | Why Work Here | |
/career/why-work-here/ | Text duplicate | Why Work Here |
/career/why-work-here/campus-l... | Campus Life | |
/career/why-work-here/life-in-... | Life in Vienna | |
/about/about-vienna-biocenter/ | About | |
/about/about-vienna-biocenter/ | About Vienna BioCenter | |
/about/vbc-at-a-glance/ | VBC at a Glance | |
/about/vbc-at-a-glance/ | Text duplicate | VBC at a Glance |
/about/vbc-at-a-glance/who-is-... | Who is Here (Members) | |
/about/vbc-at-a-glance/history/ | History | |
/about/vbc-at-a-glance/managem... | Management Team | |
/about/virtual-tour/ | Virtual Tour | |
/about/events/ | Events at the Vienna BioCenter | |
/about/news/ | News | |
/about/sustainability/ | Sustainability | |
/about/downloads/ | Downloads | |
/about/contact/ | Text duplicate | Contact |
/about/about-vienna-biocenter/ | More about us! | |
/research/key-discoveries/ | Read more! | |
/career/open-positions/ | Apply now! | |
/research/covid-19/timeline/ | Read more here! | |
/about/vbc-at-a-glance/who-is-... | GMI | |
/about/vbc-at-a-glance/who-is-... | IMBA | |
/about/vbc-at-a-glance/who-is-... | IMP | |
/about/vbc-at-a-glance/who-is-... | Max Perutz Labs | |
/about/vbc-at-a-glance/who-is-... | CeMESS | |
/about/vbc-at-a-glance/who-is-... | Faculty of Life Sciences | |
/research/research-areas/ | all areas of the life sciences | |
/about/vbc-at-a-glance/who-is-... | New window Subdomain | basic research in plants |
/research/key-discoveries/ | New window Subdomain | key discoveries |
/research/research-groups/ | 136 Research Groups | |
/vbcf/ | 10 Scientific Facilities | |
/research/research-groups/erc-... | 93 ERC grants | |
/research/research-groups/embo... | 34 EMBO members | |
/companies/biotech-companies/ | 39 Biotech Companies | |
https://training.vbc.ac.at/mas... | External Subdomain | Internships |
https://training.vbc.ac.at/sum... | External Subdomain | Summer School |
https://training.vbc.ac.at/phd... | External Subdomain | PhDs |
https://training.vbc.ac.at/pos... | External Subdomain | Postdocs |
/career/open-positions/ | Job Offers | |
/about/vbc-at-a-glance/who-is-... | Link to Page IMG-ALT GMI A-TITLE GMI | |
/about/vbc-at-a-glance/who-is-... | Text duplicate | Link to Page IMG-ALT IMBA A-TITLE IMBA |
/about/vbc-at-a-glance/who-is-... | Text duplicate | Link to Page IMG-ALT IMP A-TITLE IMP |
/about/vbc-at-a-glance/who-is-... | Text duplicate | Link to Page |
/about/vbc-at-a-glance/who-is-... | Text duplicate | Link to Page |
/about/vbc-at-a-glance/who-is-... | Text duplicate | Link to Page |
/research/key-discoveries/huma... | Text duplicate | HUMAN BRAIN ORGANOIDS A-TITLE HUMAN BRAIN ORGANOIDS |
/research/key-discoveries/huma... | Trivial anchor text Read more A-TITLE HUMAN BRAIN ORGANOIDS | |
/research/key-discoveries/cris... | Text duplicate | CRISPR/Cas9 A-TITLE CRISPR/Cas9 |
/research/key-discoveries/cris... | Text duplicate | Trivial anchor text Read more A-TITLE CRISPR/Cas9 |
/research/key-discoveries/mech... | Text duplicate | MECHANISMS OF CHROMOSOME SEGREGATION A-TITLE MECHANISMS OF CHROMOSOME SEGREGATION |
/research/key-discoveries/mech... | Text duplicate | Trivial anchor text Read more A-TITLE MECHANISMS OF CHROMOSOME SEGREGATION |
/research/key-discoveries/epig... | Text duplicate | EPIGENETICS A-TITLE EPIGENETICS |
/research/key-discoveries/epig... | Text duplicate | Trivial anchor text Read more A-TITLE EPIGENETICS |
/research/key-discoveries/1001... | Text duplicate | 1001 GENOMES A-TITLE 1001 GENOMES |
/research/key-discoveries/1001... | Text duplicate | Trivial anchor text Read more A-TITLE 1001 GENOMES |
/research/key-discoveries/ | See all Key Discoveries A-TITLE See all Key Discoveries | |
https://www.oeaw.ac.at/gmi/new... | New window External Subdomain | Trivial anchor text here |
https://www.oeaw.ac.at/imba/se... | New window External Subdomain Text duplicate | Trivial anchor text here |
https://www.oeaw.ac.at/gmi/new... | New window External Subdomain Text duplicate | Trivial anchor text here |
https://appn.at/events/4thappn/ | New window External Text duplicate | Trivial anchor text here |
/about/news/you-shall-not-pass/ | 20 Jun'24 You shall not pass A-TITLE You shall not pass | |
/about/news/survival-of-the-fi... | 20 Jun'24 Survival of the filamentous A-TITLE Survival of the filamentous | |
/about/news/all-eyes-on-the-pr... | 20 Jun'24 All Eyes on the Proteome A-TITLE All Eyes on the Proteome | |
/about/news/unrecyclable-how-p... | 12 Jun'24 Unrecyclable: how protein aggregates evade clearance A-TITLE Unrecyclable: how protein aggregates evade clearance | |
/about/news/otto-hahn-medal-an... | 12 Jun'24 Otto Hahn Medal and Award for Ida Jentoft A-TITLE Otto Hahn Medal and Award for Ida Jentoft | |
/about/news/new-perutz-princip... | 06 Jun'24 New Perutz Principal Investigator Projects funded by FWF A-TITLE New Perutz Principal Investigator Projects funded by FWF | |
/about/news/valneva-announces-... | 04 Jun'24 Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases A-TITLE Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases | |
/about/news/jacob-schreiber-to... | 04 Jun'24 Jacob Schreiber to join IMP faculty as visiting scientist A-TITLE Jacob Schreiber to join IMP faculty as visiting scientist | |
/about/news/valneva-receives-e... | 31 May'24 Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine A-TITLE Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine | |
/about/news/joris-van-der-veek... | 22 May'24 Joris van der Veeken secures FWF funding A-TITLE Joris van der Veeken secures FWF funding | |
/about/news/imp-emeritus-direc... | 20 May'24 IMP Emeritus Director Barry Dickson elected Fellow of the Royal Society A-TITLE IMP Emeritus Director Barry Dickson elected Fellow of the Royal Society | |
/about/news/bernardo-de-almeid... | 14 May'24 Bernardo de Almeida wins 2024 Denise P. Barlow Award A-TITLE Bernardo de Almeida wins 2024 Denise P. Barlow Award | |
/about/news/natures-3d-printer... | 13 May'24 Nature’s 3D Printer: Bristle Edition A-TITLE Nature’s 3D Printer: Bristle Edition | |
/about/news/time-is-of-the-ess... | 07 May'24 Time is of the essence A-TITLE Time is of the essence | |
/about/news/filip-nemcko-among... | 06 May'24 Filip Nemcko among Forbes Slovakia “30 Under 30” A-TITLE Filip Nemcko among Forbes Slovakia “30 Under 30” | |
/about/news/revving-up-the-eng... | 24 Apr'24 Revving up the engine: Immunity on Standby A-TITLE Revving up the engine: Immunity on Standby | |
/about/news/hfsp-grant-for-con... | 23 Apr'24 HFSP grant for consortium led by Kristin Tessmar-Raible A-TITLE HFSP grant for consortium led by Kristin Tessmar-Raible | |
/about/news/clemens-plaschka-e... | 15 Apr'24 Clemens Plaschka elected to ÖAW Young Academy A-TITLE Clemens Plaschka elected to ÖAW Young Academy | |
/about/news/perutz-group-leade... | 15 Apr'24 Perutz group leaders receive individual funding from FWF A-TITLE Perutz group leaders receive individual funding from FWF | |
/about/news/dont-judge-a-book-... | 11 Apr'24 Don’t judge a book by its cover A-TITLE Don’t judge a book by its cover | |
/about/news/5-erc-grants-award... | 10 Apr'24 5 ERC Grants Awarded to Vienna BioCenter Scientists A-TITLE 5 ERC Grants Awarded to Vienna BioCenter Scientists | |
/about/news/hfsp-fellowship-fo... | 09 Apr'24 HFSP Fellowship for IMP postdoc Vytaute Boreikaite A-TITLE HFSP Fellowship for IMP postdoc Vytaute Boreikaite | |
/about/news/seeing-the-unseeable/ | 09 Apr'24 Seeing the unseeable A-TITLE Seeing the unseeable | |
/about/news/fwf-and-oeaw-award... | 28 Mar'24 FWF and ÖAW award “Disruptive Innovation Grant” to Johannes Schmoellerl (IMP) A-TITLE FWF and ÖAW award “Disruptive Innovation Grant” to Johannes Schmoellerl (IMP) | |
/about/news/mass-spec-tacular-... | 26 Mar'24 Mass Spec-tacular: Proteomics at the Perutz A-TITLE Mass Spec-tacular: Proteomics at the Perutz | |
/about/news/imba-welcomes-elly... | 14 Mar'24 IMBA Welcomes Elly Tanaka as Scientific Director A-TITLE IMBA Welcomes Elly Tanaka as Scientific Director | |
/about/news/fwf-emerging-field... | 12 Mar'24 FWF Emerging Fields grant for search of immunotherapy against childhood cancer A-TITLE FWF Emerging Fields grant for search of immunotherapy against childhood cancer | |
/about/news/heart-of-the-splic... | 11 Mar'24 "Heart" of the spliceosome: putting together a molecular machine A-TITLE "Heart" of the spliceosome: putting together a molecular machine | |
/about/news/marie-sklodowska-c... | 29 Feb'24 Marie Skłodowska-Curie fellowship for Rupert Faraway to study mRNA selection mechanism A-TITLE Marie Skłodowska-Curie fellowship for Rupert Faraway to study mRNA selection mechanism | |
/about/news/three-gmi-scientis... | 28 Feb'24 Three GMI scientists awarded Marie Skłodowska-Curie Postdoctoral Fellowships A-TITLE Three GMI scientists awarded Marie Skłodowska-Curie Postdoctoral Fellowships | |
/about/news/researchers-at-the... | 17 Jan'24 Researchers at the Vienna BioCenter and in Ghana team up to advance diagnostics in Africa A-TITLE Researchers at the Vienna BioCenter and in Ghana team up to advance diagnostics in Africa | |
/about/news/funding-for-two-in... | 17 Jan'24 Funding for two interdisciplinary projects to ‘understand biology with artificial intelligence’ A-TITLE Funding for two interdisciplinary projects to ‘understand biology with artificial intelligence’ | |
/about/news/prestigious-embo-f... | 16 Jan'24 Prestigious EMBO Fellowships for two IMP postdocs A-TITLE Prestigious EMBO Fellowships for two IMP postdocs | |
/about/news/valneva-vaccinates... | 10 Jan'24 Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine A-TITLE Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine | |
/about/news/sperms-creative-ap... | 21 Dec'23 Sperm's creative approach to genome packing A-TITLE Sperm's creative approach to genome packing | |
/about/news/what-does-cooking-... | 18 Dec'23 What does cooking have to do with science? - Interview with new group leader Pim Huis in 't Veld A-TITLE What does cooking have to do with science? - Interview with new group leader Pim Huis in 't Veld | |
/about/news/how-eggs-keep-thei... | 15 Dec'23 How eggs keep their messenger RNAs quiet A-TITLE How eggs keep their messenger RNAs quiet | |
/about/news/decoding-genome-in... | 14 Dec'23 Decoding genome instability: New doc.funds initiative at the Perutz A-TITLE Decoding genome instability: New doc.funds initiative at the Perutz | |
/about/news/artificial-intelli... | 12 Dec'23 Artificial Intelligence cracks code of gene regulation A-TITLE Artificial Intelligence cracks code of gene regulation | |
/about/news/new-insights-into-... | 06 Dec'23 New insights into how B cells time the duplication of their genome IMG-ALT An hourglass sits on a white surface, in front of a dark grey background. Instead of sand, there is a double helix of DNA A-TITLE New insights into how B cells time the duplication of their genome | |
/about/news/alejandro-burga-im... | 05 Dec'23 Alejandro Burga (IMBA) and David Haselbach (IMP) join EMBO Young Investigator Program A-TITLE Alejandro Burga (IMBA) and David Haselbach (IMP) join EMBO Young Investigator Program | |
/about/news/the-stage-is-yours... | 01 Dec'23 The stage is yours, DIDO! A-TITLE The stage is yours, DIDO! | |
/about/news/first-multi-chambe... | 28 Nov'23 First multi-chamber heart organoids unravel human heart development and disease A-TITLE First multi-chamber heart organoids unravel human heart development and disease | |
/about/news/decoding-cell-fate... | 24 Nov'23 Decoding cell fate: Key mechanism in stem cell switch identified A-TITLE Decoding cell fate: Key mechanism in stem cell switch identified | |
/about/news/nine-highly-cited-... | 22 Nov'23 Nine “Highly Cited Researchers” at Vienna BioCenter in 2023 A-TITLE Nine “Highly Cited Researchers” at Vienna BioCenter in 2023 | |
/about/news/new-max-perutz-phd... | 22 Nov'23 New Max Perutz PhD fellows A-TITLE New Max Perutz PhD fellows | |
/about/news/phosphatase-loss-s... | 14 Nov'23 Phosphatase loss spells problems for the prostate A-TITLE Phosphatase loss spells problems for the prostate | |
/about/news/valneva-announces-... | 10 Nov'23 Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, IXCHIQ® A-TITLE Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, IXCHIQ® | |
/about/news/avina-grant-for-ce... | 02 Nov'23 AVINA Grant for CeMESS group leader Shaul Pollak IMG-ALT A young man with a bald head and moustache looks severely into the camera. A-TITLE AVINA Grant for CeMESS group leader Shaul Pollak | |
/about/news/why-tofu-is-good-f... | 27 Oct'23 Why TOFU is good for worms A-TITLE Why TOFU is good for worms | |
/about/news/the-last-stand-pla... | 12 Oct'23 The last stand - Plant stem cells put up a fight against viruses A-TITLE The last stand - Plant stem cells put up a fight against viruses | |
/about/news/international-birn... | 28 Sep'23 International Birnstiel Award 2023 celebrates six outstanding scientists A-TITLE International Birnstiel Award 2023 celebrates six outstanding scientists | |
/about/news/scientists-show-ho... | 21 Sep'23 Scientists show how cells build protein destruction signals A-TITLE Scientists show how cells build protein destruction signals | |
/about/news/immunologists-reve... | 19 Sep'23 Immunologists reveal how the Pax5 protein regulates B cell development and commitment IMG-ALT A young woman with bound dark hair, a white top and a mauve jacket smiles at the camera. A-TITLE Immunologists reveal how the Pax5 protein regulates B cell development and commitment | |
/about/news/choosen-fate-one-b... | 13 Sep'23 CHOOSEn fate: one brain organoid’s tale on Autism A-TITLE CHOOSEn fate: one brain organoid’s tale on Autism | |
/about/news/goldilocks-and-the... | 11 Sep'23 Goldilocks and the E3 ligase A-TITLE Goldilocks and the E3 ligase | |
/about/news/unearthing-the-hid... | 11 Sep'23 Unearthing the hidden trove of long non-coding RNAs in plants A-TITLE Unearthing the hidden trove of long non-coding RNAs in plants | |
/about/news/valneva-and-pfizer... | 07 Sep'23 Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate A-TITLE Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate | |
/about/news/broadcasting-dna-u... | 05 Sep'23 Broadcasting DNA using transposons: ERC Starting Grant for Irma Querques A-TITLE Broadcasting DNA using transposons: ERC Starting Grant for Irma Querques | |
/about/news/network-based-appr... | 01 Sep'23 Network-based approaches open a new avenue to classify and treat rare diseases IMG-ALT From left to right: Kaan Boztug, Julia Guthrie, Jörg Menche. (c) Piero Chiussi A-TITLE Network-based approaches open a new avenue to classify and treat rare diseases | |
/about/news/prestigious-fellow... | 30 Aug'23 Prestigious fellowships awarded to Max Perutz Labs PhD students IMG-ALT (from left to right) Johannes Benedum, Alexandra Shulkina, Anzhela Pavlova, Elisabeth Holzer. Credit: Max Kropitz for Max Perutz Labs A-TITLE Prestigious fellowships awarded to Max Perutz Labs PhD students | |
/about/news/lipid-chemistry-em... | 17 Aug'23 Lipid Chemistry Empowers Nuclear Shape A-TITLE Lipid Chemistry Empowers Nuclear Shape | |
/about/news/25m-euros-funding-... | 17 Aug'23 2.5M euros funding for single-cell proteomics A-TITLE 2.5M euros funding for single-cell proteomics | |
/about/news/20th-vienna-biocen... | 02 Aug'23 20th Vienna BioCenter PhD Symposium: 9/10 November 2023 IMG-ALT An illustration fo a hand in a nitril glove holds a tape; the thread of the tape writes "a mixtape of science". A-TITLE 20th Vienna BioCenter PhD Symposium: 9/10 November 2023 | |
/about/news/in-science-you-can... | 24 Jul'23 "In science, you can’t get bored" - Interview with new group leader Irma Querques A-TITLE "In science, you can’t get bored" - Interview with new group leader Irma Querques | |
/about/news/a-crispr-based-lab... | 18 Jul'23 A CRISPR-based lab tool for lineage tracing in vivo A-TITLE A CRISPR-based lab tool for lineage tracing in vivo | |
/about/news/hicognition-a-comp... | 18 Jul'23 HiCognition: A computational tool to navigate the genome in 3D A-TITLE HiCognition: A computational tool to navigate the genome in 3D | |
/about/news/fwf-awards-esprit-... | 06 Jul'23 FWF awards ESPRIT grant to study single-cell proteomics of human blastoid A-TITLE FWF awards ESPRIT grant to study single-cell proteomics of human blastoid | |
/about/news/a-cohesin-regulate... | 04 Jul'23 A cohesin-regulated tug-of-war inside chromosomes A-TITLE A cohesin-regulated tug-of-war inside chromosomes | |
/about/news/imp-senior-group-l... | 04 Jul'23 IMP Senior Group Leader Anna Obenauf elected EMBO Member A-TITLE IMP Senior Group Leader Anna Obenauf elected EMBO Member | |
/about/news/virus-like-transpo... | 29 Jun'23 Virus-like transposons wage war on the species barrier A-TITLE Virus-like transposons wage war on the species barrier | |
/about/news/how-land-plants-re... | 29 Jun'23 How land plants regulate tissue development and organogenesis A-TITLE How land plants regulate tissue development and organogenesis | |
/about/news/start-grant-for-st... | 22 Jun'23 START grant for Stephanie Ellis A-TITLE START grant for Stephanie Ellis | |
/about/news/many-roads-lead-to... | 21 Jun'23 Many roads lead to Rome A-TITLE Many roads lead to Rome | |
/about/news/3-new-fwf-grants-a... | 06 Jun'23 3 new FWF grants awarded to Max Perutz Labs scientists A-TITLE 3 new FWF grants awarded to Max Perutz Labs scientists | |
/about/news/dissecting-the-for... | 12 May'23 Dissecting the forces that govern epigenetic memory A-TITLE Dissecting the forces that govern epigenetic memory | |
/about/news/imps-elly-tanaka-e... | 03 May'23 IMP's Elly Tanaka elected to National Academy of Sciences A-TITLE IMP's Elly Tanaka elected to National Academy of Sciences | |
/about/news/hfsp-grant-awarded... | 28 Apr'23 HFSP grant awarded to Kristina Djinovic and Jonas Ries A-TITLE HFSP grant awarded to Kristina Djinovic and Jonas Ries | |
/about/news/elucidating-the-me... | 11 Apr'23 Elucidating the mechanism behind the medicine A-TITLE Elucidating the mechanism behind the medicine | |
/about/news/yasin-dagdas-elect... | 03 Apr'23 Yasin Dagdas elected to the OeAW’s Young Academy A-TITLE Yasin Dagdas elected to the OeAW’s Young Academy | |
/about/news/muscle-health-depe... | 20 Mar'23 Muscle health depends on lipid synthesis A-TITLE Muscle health depends on lipid synthesis | |
/about/news/fwf-approves-clust... | 19 Mar'23 FWF approves Cluster of Excellence with CeMESS lead A-TITLE FWF approves Cluster of Excellence with CeMESS lead | |
/about/news/alfred-hauptmann-p... | 17 Mar'23 Alfred Hauptmann Prize for research on Tuberous Sclerosis at IMBA A-TITLE Alfred Hauptmann Prize for research on Tuberous Sclerosis at IMBA | |
/about/news/traffic-jam-gene-t... | 10 Mar'23 Traffic jam: gene transcription hampers cohesin’s travel along chromosomes A-TITLE Traffic jam: gene transcription hampers cohesin’s travel along chromosomes | |
/about/news/win-some-lose-some... | 03 Mar'23 Win some – lose some: how cells adapt to aneuploidy A-TITLE Win some – lose some: how cells adapt to aneuploidy | |
/about/news/the-dual-face-of-p... | 03 Mar'23 The dual face of photoreceptors during seed germination A-TITLE The dual face of photoreceptors during seed germination | |
/about/news/egon-macher-award-... | 24 Feb'23 Egon Macher Award for Lukas Leiendecker IMG-ALT A young man wearing a white shirt and a black jacket smiles at the camera. A-TITLE Egon Macher Award for Lukas Leiendecker | |
/about/news/learning-from-viru... | 21 Feb'23 Learning from viruses A-TITLE Learning from viruses | |
/about/news/embryos-gaining-in... | 14 Feb'23 Embryos gaining independence A-TITLE Embryos gaining independence | |
/about/news/valneva-completes-... | 14 Feb'23 Valneva Completes Enrollment for Adolescent Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate A-TITLE Valneva Completes Enrollment for Adolescent Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate | |
/about/news/autophagy-the-mole... | 10 Feb'23 Autophagy: The molecular regulation of self-eating A-TITLE Autophagy: The molecular regulation of self-eating | |
/about/news/do-it-yourself-kin... | 10 Feb'23 Do it yourself – kinase activation revisited A-TITLE Do it yourself – kinase activation revisited | |
/about/news/guardian-of-the-ce... | 09 Feb'23 "Guardian of the Cell": structure and key function of giant protein explained A-TITLE "Guardian of the Cell": structure and key function of giant protein explained | |
/about/news/a-tale-of-dna-loop... | 02 Feb'23 A tale of DNA loops: how distant DNA segments come together to make different types of antibodies IMG-ALT A DNA double helix is in the foreground, two other DNA molecules in the background, forming loops. The DNA molecules are bright orange and cyan on a black ba... A-TITLE A tale of DNA loops: how distant DNA segments come together to make different types of antibodies | |
/about/news/stressing-out-the-... | 30 Jan'23 Stressing out the immune system A-TITLE Stressing out the immune system | |
/about/news/snsf-fellowship-fo... | 27 Jan'23 SNSF fellowship for postdoc Milica Vulin IMG-ALT A young woman with dark brown hair stands and smiles at the camera. A-TITLE SNSF fellowship for postdoc Milica Vulin | |
/about/news/bryophytes-branch-... | 24 Jan'23 Bryophytes branch differently... also at the molecular level A-TITLE Bryophytes branch differently... also at the molecular level | |
/about/news/switch-it-off-new-... | 23 Jan'23 Switch it off: new insights into repressors of gene transcription IMG-ALT A young woman dressed in a black v-neck t-shirt, blond with blue eyes, smiles at the camera. A-TITLE Switch it off: new insights into repressors of gene transcription | |
/about/news/coping-with-chromo... | 20 Jan'23 Coping with chromosomal stress A-TITLE Coping with chromosomal stress | |
/about/news/portrait-of-a-prot... | 16 Jan'23 Portrait of a protein family A-TITLE Portrait of a protein family | |
/about/news/weiss-kruszka-synd... | 05 Jan'23 Weiss-Kruszka syndrome and the failure to establish neuronal identity A-TITLE Weiss-Kruszka syndrome and the failure to establish neuronal identity | |
/about/news/punching-holes-in-... | 05 Jan'23 Punching holes in the nucleus A-TITLE Punching holes in the nucleus | |
/about/news/fwf-awards-docfund... | 07 Dec'22 FWF awards doc.funds and stand alone project grants A-TITLE FWF awards doc.funds and stand alone project grants | |
/about/news/valneva-reports-po... | 05 Dec'22 Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate A-TITLE Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate | |
/about/news/valneva-and-pfizer... | 01 Dec'22 Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate A-TITLE Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate | |
/about/news/sebastian-falk-joi... | 28 Nov'22 Sebastian Falk joins EMBO Young Investigator program A-TITLE Sebastian Falk joins EMBO Young Investigator program | |
/about/news/awakening-the-genome/ | 24 Nov'22 Awakening the genome A-TITLE Awakening the genome | |
/about/news/erc-starting-grant... | 22 Nov'22 ERC Starting Grants for Joanna Jachowicz and Kelly Swarts A-TITLE ERC Starting Grants for Joanna Jachowicz and Kelly Swarts | |
/about/news/revealing-the-arch... | 21 Nov'22 Revealing the architectural secrets inside mini-organs IMG-ALT A bright magenta circle on a black background. Inside the magenta circle, a whit circle and filamentous brigt green structures. A-TITLE Revealing the architectural secrets inside mini-organs | |
/about/news/max-on-the-wall/ | 11 Nov'22 Max on the wall A-TITLE Max on the wall | |
/about/news/awards-of-the-vien... | 09 Nov'22 Awards of the Vienna BioCenter PhD Symposium 2022 A-TITLE Awards of the Vienna BioCenter PhD Symposium 2022 | |
/about/news/hushing-repetitive... | 04 Nov'22 HUSHing repetitive-like elements contributes to normal brain development and function A-TITLE HUSHing repetitive-like elements contributes to normal brain development and function | |
/about/news/fwf-grants-awarded... | 02 Nov'22 FWF grants awarded to Max Perutz Labs scientists IMG-ALT Roland Foisner, Martin Leeb, Thomas Leonard (c) Max Perutz Labs A-TITLE FWF grants awarded to Max Perutz Labs scientists | |
/about/news/new-stop-along-the... | 19 Oct'22 New stop along the cellular journey of recycling organelles in plants A-TITLE New stop along the cellular journey of recycling organelles in plants | |
/about/news/old-drugs-new-tricks/ | 14 Oct'22 Old drugs new tricks A-TITLE Old drugs new tricks | |
/about/news/valneva-to-present... | 10 Oct'22 Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences A-TITLE Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences | |
/about/news/kipferl-guiding-th... | 04 Oct'22 “Kipferl”: Guiding the defense against jumping genes A-TITLE “Kipferl”: Guiding the defense against jumping genes | |
/about/news/new-light-for-elec... | 30 Sep'22 New light for electron microscopy A-TITLE New light for electron microscopy | |
/about/news/circalunar-clocks-... | 09 Sep'22 Circalunar clocks: using the right light A-TITLE Circalunar clocks: using the right light | |
/about/news/breaking-down-prot... | 08 Sep'22 Breaking down proteins: How starving cancer cells switch food sources A-TITLE Breaking down proteins: How starving cancer cells switch food sources | |
/about/news/stephanie-ellis-na... | 01 Sep'22 Stephanie Ellis named a 2022 Vallee Scholar A-TITLE Stephanie Ellis named a 2022 Vallee Scholar | |
/about/news/old-drugs-hint-at-... | 31 Aug'22 Old drugs hint at new ways to beat chronic pain A-TITLE Old drugs hint at new ways to beat chronic pain | |
/about/news/conversing-with-th... | 30 Aug'22 Conversing with the past: how evolution shaped the human mind A-TITLE Conversing with the past: how evolution shaped the human mind | |
/about/news/where-art-and-scie... | 29 Aug'22 Where art and science meet A-TITLE Where art and science meet | |
/about/news/when-mothers-shut-... | 23 Aug'22 When mothers shut down the fathers’ genes in the embryo A-TITLE When mothers shut down the fathers’ genes in the embryo | |
/about/news/transcription-fact... | 10 Aug'22 Transcription factor PAX5 linked to antibody deficiency and brain development A-TITLE Transcription factor PAX5 linked to antibody deficiency and brain development | |
/about/news/pfizer-and-valneva... | 08 Aug'22 Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 A-TITLE Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 | |
/about/news/how-the-genome-is-... | 03 Aug'22 How the genome is packed into chromosomes that can be faithfully moved during cell division A-TITLE How the genome is packed into chromosomes that can be faithfully moved during cell division | |
/about/news/receptor-fibcd1-ne... | 02 Aug'22 Receptor FIBCD1 newly identified in neuro-developmental disorders A-TITLE Receptor FIBCD1 newly identified in neuro-developmental disorders | |
/about/news/aaas-wachtel-cance... | 27 Jul'22 AAAS Wachtel Cancer Research Award 2022 for Anna Obenauf (IMP) A-TITLE AAAS Wachtel Cancer Research Award 2022 for Anna Obenauf (IMP) | |
/about/news/on-standby-how-the... | 19 Jul'22 On standby: how the developing embryo guards against viral infection A-TITLE On standby: how the developing embryo guards against viral infection | |
/about/news/the-axolotl-a-new-... | 14 Jul'22 The axolotl, a new model to improve the healing of broken bones A-TITLE The axolotl, a new model to improve the healing of broken bones | |
/about/news/the-beginning-of-l... | 07 Jul'22 The beginning of life: The early embryo is in the driver's seat A-TITLE The beginning of life: The early embryo is in the driver's seat | |
/about/news/johannes-zuber-ele... | 06 Jul'22 Johannes Zuber elected EMBO Member A-TITLE Johannes Zuber elected EMBO Member | |
/about/news/cebina-publishes-d... | 06 Jul'22 CEBINA publishes data demonstrating the anti-histamine azelastine inhibits infection by major variants of SARS-CoV-2 A-TITLE CEBINA publishes data demonstrating the anti-histamine azelastine inhibits infection by major variants of SARS-CoV-2 | |
/about/news/the-idea-is-to-con... | 05 Jul'22 “The idea is to connect people” - Manuela Baccarini elected Vice-Rector of the University of Vienna A-TITLE “The idea is to connect people” - Manuela Baccarini elected Vice-Rector of the University of Vienna | |
/about/news/exhibition-about-m... | 01 Jul'22 Exhibition about Max Perutz draws over 5.000 visitors A-TITLE Exhibition about Max Perutz draws over 5.000 visitors | |
/about/news/cherish-the-beginn... | 01 Jul'22 “Cherish the beginning” - Interview with new group leader Stephanie Ellis A-TITLE “Cherish the beginning” - Interview with new group leader Stephanie Ellis | |
/about/news/climatemaxperutzla... | 24 Jun'22 Climate@MaxPerutzLabs initiative wins Austrian Sustainability Award 2022 A-TITLE Climate@MaxPerutzLabs initiative wins Austrian Sustainability Award 2022 | |
/about/news/valneva-receives-m... | 24 Jun'22 Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001 A-TITLE Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001 | |
/about/news/anna-obenauf-and-a... | 22 Jun'22 Anna Obenauf and Andrea Pauli promoted to Senior Scientists IMG-ALT Two young women stand next to each other with crossed arms and smile at the camera. A-TITLE Anna Obenauf and Andrea Pauli promoted to Senior Scientists | |
/about/news/valneva-and-pfizer... | 20 Jun'22 Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15 A-TITLE Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15 | |
/about/news/oeaw-doc-fellowshi... | 09 Jun'22 ÖAW DOC Fellowships awarded to Max Perutz Labs students A-TITLE ÖAW DOC Fellowships awarded to Max Perutz Labs students | |
/about/news/tracking-cells-in-... | 09 Jun'22 Tracking cells in the regenerating limb through space and time IMG-ALT A young man with black hair and eyes, glasses, and a light red t-shirt sits on a terrace and smiles at the camera. A-TITLE Tracking cells in the regenerating limb through space and time | |
/about/news/bacprotacs-antibio... | 03 Jun'22 BacPROTACs: antibiotics of the future IMG-ALT A pink molecule is attached to a large green and blue enzyme via a small orange molecule. On the other side of the enzyme, small bits of pink come out. A-TITLE BacPROTACs: antibiotics of the future | |
/about/news/putting-a-finger-o... | 02 Jun'22 Putting a finger on meiosis A-TITLE Putting a finger on meiosis | |
/about/news/milestone-in-under... | 01 Jun'22 Milestone in understanding regulation of gene transcription IMG-ALT A young man and a young woman stand back to back and smile at the camera. A-TITLE Milestone in understanding regulation of gene transcription | |
/about/news/rendezvous-at-nigh... | 01 Jun'22 Rendezvous at night – how moonlight fine-tunes animal reproduction A-TITLE Rendezvous at night – how moonlight fine-tunes animal reproduction | |
/about/news/undergraduate-stud... | 01 Jun'22 Undergraduate student fits one more piece to the regeneration puzzle IMG-ALT A young man with brown eyes, a white t-shirt and beige shirt smiles at the camera. A-TITLE Undergraduate student fits one more piece to the regeneration puzzle | |
/about/news/erc-proof-of-conce... | 30 May'22 ERC Proof of Concept to investigate clinical applications of blastoids A-TITLE ERC Proof of Concept to investigate clinical applications of blastoids | |
/about/news/anna-obenauf-part-... | 26 May'22 Anna Obenauf part of international consortium to study bone cancer IMG-ALT A young woman with brown hair and eyes, a white jacket and orange shirt smiles at the camera. A-TITLE Anna Obenauf part of international consortium to study bone cancer | |
/about/news/diana-pinheiro-to-... | 23 May'22 Diana Pinheiro to establish research group at IMP IMG-ALT A young woman with brown hair and eyes, a fine necklace, a shite shirt and a grey cardigan smiles at the camera. A-TITLE Diana Pinheiro to establish research group at IMP | |
/about/news/an-open-source-cov... | 20 May'22 An open-source COVID-19 test empowers African diagnostics and research A-TITLE An open-source COVID-19 test empowers African diagnostics and research | |
/about/news/austrian-science-f... | 19 May'22 Austrian Science Fund supports heart regeneration research for next four years A-TITLE Austrian Science Fund supports heart regeneration research for next four years | |
/about/news/ema-accepts-filing... | 19 May'22 EMA accepts filing of marketing authorization application for Valneva’s inactivated COVID-19 Vaccine Candidate A-TITLE EMA accepts filing of marketing authorization application for Valneva’s inactivated COVID-19 Vaccine Candidate | |
/about/news/imp-postdoc-paul-m... | 17 May'22 IMP Postdoc Paul Murphy joins the ESPRIT Programme A-TITLE IMP Postdoc Paul Murphy joins the ESPRIT Programme | |
/about/news/embo-fellowship-fo... | 16 May'22 EMBO Fellowship for IMP postdoc Franziska Lorbeer A-TITLE EMBO Fellowship for IMP postdoc Franziska Lorbeer | |
/about/news/harnessing-artific... | 12 May'22 Harnessing artificial intelligence to predict and control gene regulation A-TITLE Harnessing artificial intelligence to predict and control gene regulation | |
/about/news/science-for-resili... | 12 May'22 Science for Resilience: Conference at Vienna BioCenter to discuss outlooks on Covid-19 A-TITLE Science for Resilience: Conference at Vienna BioCenter to discuss outlooks on Covid-19 | |
/about/news/alwin-koehler-elec... | 12 May'22 Alwin Köhler elected corresponding member of the Austrian Academy of Sciences A-TITLE Alwin Köhler elected corresponding member of the Austrian Academy of Sciences | |
/about/news/city-of-vienna-pri... | 10 May'22 City of Vienna Prize presented to Meinrad Busslinger and Jürgen Knoblich A-TITLE City of Vienna Prize presented to Meinrad Busslinger and Jürgen Knoblich | |
/about/news/imp-scientists-sol... | 09 May'22 IMP scientists solve first plant proteasome structure with supermarket spinach A-TITLE IMP scientists solve first plant proteasome structure with supermarket spinach | |
/about/news/sciencechatimba-do... | 05 May'22 #ScienceChatIMBA: Double agents - How stomach stem cells change allegiance upon injury IMG-ALT Normal mouse stomach epithelium (above) versus epithelium with p57 overexpression (below) at day 3 post-injury with high-dose tamoxifen (HDT). The epithelium... A-TITLE #ScienceChatIMBA: Double agents - How stomach stem cells change allegiance upon injury | |
/about/news/austrian-academy-o... | 05 May'22 Austrian Academy of Sciences honours Elly Tanaka with full membership A-TITLE Austrian Academy of Sciences honours Elly Tanaka with full membership | |
/about/news/squid-genome-sheds... | 04 May'22 Squid genome sheds light on extraordinary brain evolution A-TITLE Squid genome sheds light on extraordinary brain evolution | |
/about/news/f-ulrich-hartl-to-... | 03 May'22 F.-Ulrich Hartl to give Max Birnstiel Lecture A-TITLE F.-Ulrich Hartl to give Max Birnstiel Lecture | |
/about/news/dna-loop-formation... | 28 Apr'22 DNA loop formation linked to Cornelia de Lange Syndrome A-TITLE DNA loop formation linked to Cornelia de Lange Syndrome | |
/about/news/scientists-discove... | 26 Apr'22 Scientists discover essential role of two proteins for fertilisation A-TITLE Scientists discover essential role of two proteins for fertilisation | |
/about/news/valneva-and-pfizer... | 26 Apr'22 Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate A-TITLE Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate | |
/about/news/msca-postdoc-fello... | 19 Apr'22 MSCA Postdoc Fellowship for Elias Adriaenssens A-TITLE MSCA Postdoc Fellowship for Elias Adriaenssens | |
/about/news/valneva-receives-c... | 14 Apr'22 Valneva Receives Conditional Marketing Authorization from UK MHRA for its Inactivated COVID-19 Vaccine A-TITLE Valneva Receives Conditional Marketing Authorization from UK MHRA for its Inactivated COVID-19 Vaccine | |
/about/news/new-lessons-from-a... | 07 Apr'22 New lessons from an old master A-TITLE New lessons from an old master | |
/about/news/fwf-stand-alone-gr... | 28 Mar'22 FWF Stand-Alone grants awarded to Max Perutz Labs scientists A-TITLE FWF Stand-Alone grants awarded to Max Perutz Labs scientists | |
/about/news/minister-of-educat... | 24 Mar'22 Minister of Education, Science and Research visits Vienna BioCenter A-TITLE Minister of Education, Science and Research visits Vienna BioCenter | |
/about/news/erc-consolidator-g... | 17 Mar'22 ERC Consolidator Grants for Andrea Pauli and Yasin Dagdas IMG-ALT VBC Group Leaders Andrea Pauli (IMP) and Yasin Dagdas (GMI). ©GMI/IMP/VBC A-TITLE ERC Consolidator Grants for Andrea Pauli and Yasin Dagdas | |
/about/news/valneva-successful... | 08 Mar'22 Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate A-TITLE Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate | |
/about/news/max-perutz-phd-fel... | 08 Mar'22 Max Perutz PhD Fellowships awarded A-TITLE Max Perutz PhD Fellowships awarded | |
/about/news/cell-fate-determin... | 07 Mar'22 Cell fate determination: making sense out of nonsense A-TITLE Cell fate determination: making sense out of nonsense | |
/about/news/ignaz-lieben-prize... | 04 Mar'22 Ignaz Lieben Prize awarded to Kristin Tessmar-Raible A-TITLE Ignaz Lieben Prize awarded to Kristin Tessmar-Raible | |
/about/news/resistance-and-tol... | 02 Mar'22 Resistance and tolerance: two sides of the same coin A-TITLE Resistance and tolerance: two sides of the same coin | |
/about/news/valneva-receives-e... | 01 Mar'22 Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA2001 A-TITLE Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA2001 | |
/about/news/valneva-receives-i... | 25 Feb'22 Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 A-TITLE Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 | |
/about/news/peter-schloegelhof... | 22 Feb'22 Peter Schlögelhofer promoted to University Professor A-TITLE Peter Schlögelhofer promoted to University Professor | |
/about/news/valneva-awarded-up... | 21 Feb'22 Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development A-TITLE Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development | |
/about/news/keeping-meiotic-en... | 17 Feb'22 Keeping meiotic entry in check IMG-ALT Image shows the distal part of the C. elegans gonad in wild type and the ppm-1-D mutant. CYE-1 (in magenta) marks the progenitor cell zone (which contains st... A-TITLE Keeping meiotic entry in check | |
/about/news/how-a-small-rna-pa... | 16 Feb'22 How a small RNA pathway talks to the heterochromatin machinery A-TITLE How a small RNA pathway talks to the heterochromatin machinery | |
/about/news/aiming-for-the-bas... | 14 Feb'22 Aiming for the basket A-TITLE Aiming for the basket | |
/about/news/moritz-gaidt-to-st... | 14 Feb'22 Moritz Gaidt to study innate immunology at IMP A-TITLE Moritz Gaidt to study innate immunology at IMP | |
/about/news/erc-grant-for-thom... | 11 Feb'22 ERC grant for Thomas Juffmann A-TITLE ERC grant for Thomas Juffmann | |
/about/news/blooming-too-soon-... | 04 Feb'22 Blooming too soon: timing is crucial to error-free cell division A-TITLE Blooming too soon: timing is crucial to error-free cell division | |
/about/news/stay-positive-how-... | 04 Feb'22 Stay positive – how the brain incites mice to react positively to both fear and reward A-TITLE Stay positive – how the brain incites mice to react positively to both fear and reward | |
/about/news/not-all-brains-are... | 27 Jan'22 Not all brains are equal: Why the human brain is more vulnerable to disease A-TITLE Not all brains are equal: Why the human brain is more vulnerable to disease | |
/about/news/of-inclusive-scien... | 27 Jan'22 Of inclusive science and exceptional mentoring: science communication award for Victoria Deneke A-TITLE Of inclusive science and exceptional mentoring: science communication award for Victoria Deneke | |
/about/news/imp-students-chara... | 21 Jan'22 IMP students characterise a sperm protein essential for zebrafish fertilisation A-TITLE IMP students characterise a sperm protein essential for zebrafish fertilisation | |
/about/news/new-funding-for-me... | 20 Jan'22 New funding for meiosis research IMG-ALT Involved Max Perutz Labs group leaders, from top left to bottom right: Christopher Campbell, Alexander Dammermann, Verena Jantsch, Franz Klein, Joao Matos, P... A-TITLE New funding for meiosis research | |
/about/news/valnevas-inactivat... | 20 Jan'22 Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant A-TITLE Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant | |
/about/news/bhlhe40-a-molecula... | 17 Jan'22 Bhlhe40, a molecular gatekeeper that prevents the formation of lymphomas A-TITLE Bhlhe40, a molecular gatekeeper that prevents the formation of lymphomas | |
/about/news/valneva-confirms-c... | 06 Jan'22 Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001 A-TITLE Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001 | |
/about/news/tim-clausen-and-co... | 23 Dec'21 Tim Clausen and collaborators secure two prestigious grants A-TITLE Tim Clausen and collaborators secure two prestigious grants | |
/about/news/cebina-reports-bro... | 11 Dec'21 CEBINA reports broad anti-viral potency of azelastine has potential for use against influenza and RSV infections in addition to SARS-CoV-2 and its ... A-TITLE CEBINA reports broad anti-viral potency of azelastine has potential for use against influenza and RSV infections in addition to SARS-CoV-2 and its variants o... | |
/about/news/anna-obenauf-and-c... | 08 Dec'21 Anna Obenauf and Clemens Plaschka elected EMBO Young Investigators IMG-ALT A woman on the left and a man on the right look and smile at the camera. Wooden background. A-TITLE Anna Obenauf and Clemens Plaschka elected EMBO Young Investigators | |
/about/news/sanofi-to-acquire-... | 03 Dec'21 Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy A-TITLE Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy | |
/about/news/phagomed-becomes-b... | 03 Dec'21 PhagoMed becomes BioNTech R&D (Austria) A-TITLE PhagoMed becomes BioNTech R&D (Austria) | |
/about/news/breakthrough-resea... | 02 Dec'21 Breakthrough research on human blastoids and impact on IVF and contraception A-TITLE Breakthrough research on human blastoids and impact on IVF and contraception | |
/about/news/valneva-confirms-i... | 02 Dec'21 Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine Program VLA2001 A-TITLE Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine Program VLA2001 | |
/about/news/valneva-and-idt-bi... | 30 Nov'21 Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001 A-TITLE Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001 | |
/about/news/prestigious-prize-... | 29 Nov'21 Prestigious prize of the Austrian Society of Allergology and Immunology for Louisa Hill IMG-ALT A young woman wearing glasses smiles at the camera. She has long brown hair and a black shirt. A-TITLE Prestigious prize of the Austrian Society of Allergology and Immunology for Louisa Hill | |
/about/news/anete-romanauska-w... | 26 Nov'21 Anete Romanauska wins Science & SciLifeLab Prize A-TITLE Anete Romanauska wins Science & SciLifeLab Prize | |
/about/news/cry2-a-component-o... | 24 Nov'21 CRY2, a component of the bird internal clock IMG-ALT Layers of dark blue cells are interspersed with fluorescent green layers. A-TITLE CRY2, a component of the bird internal clock | |
/about/news/valneva-signs-purc... | 23 Nov'21 Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001 A-TITLE Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001 | |
/about/news/network-medicine-d... | 09 Nov'21 ‘Network medicine’ directs disease diagnosis A-TITLE ‘Network medicine’ directs disease diagnosis | |
/about/news/melanie-de-almeida... | 08 Nov'21 Melanie de Almeida wins the Lauwers Award IMG-ALT A young woman with long brown hair smiles at the camera. She is wearing a mustard yellow shirt and sits on a pale gray couch. A-TITLE Melanie de Almeida wins the Lauwers Award | |
/about/news/decoding-the-role-... | 05 Nov'21 Decoding the role of PHF3 in transcription A-TITLE Decoding the role of PHF3 in transcription | |
/about/news/vienna-biocenter-p... | 04 Nov'21 Vienna BioCenter PhD Awards 2021 for two IMP and two IMBA graduates IMG-ALT Three young men and one young woman stand on a stage. Each holds a frame with an award that reads "VBC PhD Award". A-TITLE Vienna BioCenter PhD Awards 2021 for two IMP and two IMBA graduates | |
/about/news/how-cells-keep-the... | 28 Oct'21 How cells keep their nucleus clean: a fundamental discovery IMG-ALT A light blue blob is attached to two elongated orange shapes that seem to pull it through a hole in a purple surface. A-TITLE How cells keep their nucleus clean: a fundamental discovery | |
/about/news/ares-genetics-laun... | 27 Oct'21 Ares Genetics launches AREScloud for the analysis of sequenced clinical isolates A-TITLE Ares Genetics launches AREScloud for the analysis of sequenced clinical isolates | |
/about/news/fwf-grants-awarded... | 22 Oct'21 FWF grants awarded to Max Perutz Labs researchers A-TITLE FWF grants awarded to Max Perutz Labs researchers | |
/about/news/prestigious-grants... | 18 Oct'21 Prestigious grants for Rushad Pavri and Wouter Masselink A-TITLE Prestigious grants for Rushad Pavri and Wouter Masselink | |
/about/news/valneva-reports-po... | 18 Oct'21 Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 A-TITLE Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 | |
/about/news/mir-1-an-ancient-m... | 15 Oct'21 miR-1: an ancient molecule controls muscle physiology A-TITLE miR-1: an ancient molecule controls muscle physiology | |
/about/news/louisa-hill-wins-t... | 08 Oct'21 Louisa Hill wins the Rabitsch Award 2021 A-TITLE Louisa Hill wins the Rabitsch Award 2021 | |
/about/news/mission-possible-h... | 07 Oct'21 Mission possible: how cohesin fits two meters of DNA into a human cell IMG-ALT Two blue circles represent the cell nucleus, in which a long yellow and blue double-helix of DNA is folded by a wishbone-shaped, red molecule. A-TITLE Mission possible: how cohesin fits two meters of DNA into a human cell | |
/about/news/international-birn... | 01 Oct'21 International Birnstiel Award 2021 for six outstanding young scientists IMG-ALT A trophy made of steal and glass sits on a dark grey surface. A-TITLE International Birnstiel Award 2021 for six outstanding young scientists | |
/about/news/there-is-only-one-... | 01 Oct'21 “Always try to disprove your results” A-TITLE “Always try to disprove your results” | |
/about/news/valneva-and-pfizer... | 28 Sep'21 Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate A-TITLE Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate | |
/about/news/how-to-detox-the-n... | 27 Sep'21 How to detox the nucleus of unsaturated fat A-TITLE How to detox the nucleus of unsaturated fat | |
/about/news/valneva-completes-... | 14 Sep'21 Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 Vaccine A-TITLE Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 Vaccine | |
/about/news/this-is-one-of-the... | 10 Sep'21 “This is one of the best times to do science” IMG-ALT Stefan Ameres (c) Max Kropitz for Max Perutz Labs A-TITLE “This is one of the best times to do science” | |
/about/news/federal-minister-o... | 31 Aug'21 Federal Minister of Health Wolfgang Mückstein visits Vienna BioCenter A-TITLE Federal Minister of Health Wolfgang Mückstein visits Vienna BioCenter | |
/about/news/close-friends-and-... | 31 Aug'21 Close friends and distant relatives IMG-ALT Illustration of the meiotic DNA double strand break (DSB) core complex (composed of SPO11-1 (dark blue), SPO11-2 (light blue) and 2 MTOPVIb proteins (red)) a... A-TITLE Close friends and distant relatives | |
/about/news/valneva-commences-... | 23 Aug'21 Valneva Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine A-TITLE Valneva Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine | |
/about/news/vbc-summer-school-... | 20 Aug'21 Vienna BioCenter Summer School welcomes 15 students from around the world IMG-ALT A group of 14 people stand on a staircase, facing the camera. A-TITLE Vienna BioCenter Summer School welcomes 15 students from around the world | |
/about/news/petisco-a-multi-to... | 20 Aug'21 PETISCO - a multi-tool for piRNA processing A-TITLE PETISCO - a multi-tool for piRNA processing | |
/about/news/proteus-changes-hi... | 13 Aug'21 Proteus changes his Akt IMG-ALT Woodcut print of Greek sea god Proteus. Displayed in the Book of Emblems by Andrea Alciato (1531). Public Domain A-TITLE Proteus changes his Akt | |
/about/news/valneva-initiates-... | 12 Aug'21 Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate A-TITLE Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate | |
/about/news/tardigrades-take-t... | 05 Aug'21 "Tardigrades take the stage" - Adrià Nogales Moral about his research topic and scientific outreach A-TITLE "Tardigrades take the stage" - Adrià Nogales Moral about his research topic and scientific outreach | |
/about/news/valneva-announces-... | 05 Aug'21 Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate A-TITLE Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate | |
/about/news/analysis-of-sars-c... | 24 Jul'21 Vienna BioCenter researchers hone method for low-cost mass analysis of SARS-CoV-2 mutations A-TITLE Vienna BioCenter researchers hone method for low-cost mass analysis of SARS-CoV-2 mutations | |
/about/news/the-embassy-of-the... | 21 Jul'21 The Embassy of the State of Israel visits the Vienna BioCenter A-TITLE The Embassy of the State of Israel visits the Vienna BioCenter | |
/about/news/an-internship-prog... | 21 Jul'21 An internship program for Salvadoran students at the IMP A-TITLE An internship program for Salvadoran students at the IMP | |
/about/news/https-wwwmaxperutz... | 15 Jul'21 Signal transduction: In the right place, at the right time IMG-ALT Wild-type Sgk3 (red) localizes to PI3P-decorated endosomes in HeLa cells. Sgk3 mutated in its PI3P binding site (green) localizes throughout the cytoplasm. P... A-TITLE Signal transduction: In the right place, at the right time | |
/about/news/cross-resistance-w... | 15 Jul'21 Cross-resistance: when cancer therapy backfires A-TITLE Cross-resistance: when cancer therapy backfires | |
/about/news/valneva-awarded-fd... | 08 Jul'21 Valneva Awarded FDA Breakthrough Designation for its Single-Shot Chikungunya Vaccine Candidate A-TITLE Valneva Awarded FDA Breakthrough Designation for its Single-Shot Chikungunya Vaccine Candidate | |
/about/news/boehringer-ingelhe... | 07 Jul'21 Boehringer Ingelheim awards the Grass Roots Innovation Prize to a:head bio AG A-TITLE Boehringer Ingelheim awards the Grass Roots Innovation Prize to a:head bio AG | |
/about/news/valneva-to-host-sy... | 06 Jul'21 Valneva to Host Symposium on COVID-19 and Chikungunya Vaccine Candidates at 31st European Congress of Clinical Microbiology & Infectious Diseases A-TITLE Valneva to Host Symposium on COVID-19 and Chikungunya Vaccine Candidates at 31st European Congress of Clinical Microbiology & Infectious Diseases | |
/about/news/hitting-the-right-... | 06 Jul'21 Hitting the right note in dialysis care A-TITLE Hitting the right note in dialysis care | |
/about/news/max-perutz-phd-fel... | 01 Jul'21 Max Perutz PhD Fellowships IMG-ALT Luis Miguel Cerron Alvan (l), Helena Bragulat Teixidor (r), (c) Max Perutz Labs A-TITLE Max Perutz PhD Fellowships | |
/about/news/profiling-gene-exp... | 21 Jun'21 Profiling gene expression in plant embryos one nucleus at a time A-TITLE Profiling gene expression in plant embryos one nucleus at a time | |
/about/news/hot-off-the-press-... | 21 Jun'21 Hot off the press: a new role for histone modifications in genomic imprinting A-TITLE Hot off the press: a new role for histone modifications in genomic imprinting | |
/about/news/oeaw-doc-fellowshi... | 15 Jun'21 ÖAW DOC Fellowships for Max Perutz Labs students IMG-ALT Helena Bragulat Teixidor (back, left), Dana Abdeen (back, right), Daria Filipczak (front, left), Aleksandra Anisimova (front, right). (c) Max Perutz Labs A-TITLE ÖAW DOC Fellowships for Max Perutz Labs students | |
/about/news/cebina-announces-t... | 14 Jun'21 CEBINA announces the launch of Danube Labs A-TITLE CEBINA announces the launch of Danube Labs | |
/about/news/amygdala-a-piece-i... | 14 Jun'21 Amygdala: a piece in the puzzle of pain A-TITLE Amygdala: a piece in the puzzle of pain | |
/about/news/valneva-completes-... | 10 Jun'21 Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate A-TITLE Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate | |
/about/news/meiosis-mind-the-gap/ | 09 Jun'21 Meiosis: Mind the gap IMG-ALT The left panel corresponds to an artistic collage, showing Spo11-complexes (blue and yellow shapes) that cleave pieces out of chromosomes (shown in black). R... A-TITLE Meiosis: Mind the gap | |
/about/news/disrupting-ribosom... | 09 Jun'21 Disrupting ribosome production – renewed potential for cancer therapy A-TITLE Disrupting ribosome production – renewed potential for cancer therapy | |
/about/news/two-max-perutz-lab... | 08 Jun'21 Two Max Perutz Labs scientists elected as EMBO members IMG-ALT Alwin Köhler (c) Max Kropitz for Max Perutz Labs A-TITLE Two Max Perutz Labs scientists elected as EMBO members | |
/about/news/valneva-completes-... | 03 Jun'21 Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate A-TITLE Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate | |
/about/news/colouring-tumours-... | 02 Jun'21 Colouring tumours reveals their bad influence A-TITLE Colouring tumours reveals their bad influence | |
/about/news/building-muscles-f... | 31 May'21 Building muscles from liquids – phase separation in the Z-disc IMG-ALT Fusion FATZ‐1 droplets , (c) Sponga et. al 2021 A-TITLE Building muscles from liquids – phase separation in the Z-disc | |
/about/news/biology-in-the-hol... | 27 May'21 Biology in the holodeck: exploring cellular interactions with virtual reality IMG-ALT Group Leader Jörg Menche (c) Max Kropitz for Max Perutz Labs A-TITLE Biology in the holodeck: exploring cellular interactions with virtual reality | |
/about/news/sarseq/ | 25 May'21 Harnessing Next Generation Sequencing to detect SARS-CoV-2 and prepare for the next pandemic A-TITLE Harnessing Next Generation Sequencing to detect SARS-CoV-2 and prepare for the next pandemic | |
/about/news/valneva-to-partici... | 19 May'21 Valneva to Participate in the World’s First COVID-19 Vaccine Booster Trial in the UK A-TITLE Valneva to Participate in the World’s First COVID-19 Vaccine Booster Trial in the UK | |
/about/news/imp-scientists-put... | 17 May'21 IMP scientists put limb regeneration under the lens A-TITLE IMP scientists put limb regeneration under the lens | |
/about/news/birnstiel-award-2021/ | 12 May'21 International Birnstiel Award opens 2021 call A-TITLE International Birnstiel Award opens 2021 call | |
/about/news/anete-romanauska-r... | 11 May'21 Anete Romanauska receives Denise P. Barlow Award IMG-ALT Postdoc Anete Romanauska with her Denise P. Barlow Award. (c) private, Max Perutz Labs A-TITLE Anete Romanauska receives Denise P. Barlow Award | |
/about/news/valneva-announces-... | 06 May'21 Valneva Announces the Pricing of its Initial Public Offering on Nasdaq A-TITLE Valneva Announces the Pricing of its Initial Public Offering on Nasdaq | |
/about/news/a-protein-bodyguar... | 29 Apr'21 A protein bodyguard – private security in the defense against oxidation IMG-ALT To endure oxidative conditions, RTCB (bottom half) co-evolved with the dedicated protector PYROXD1 (depicted holding a shield). PYROXD1 utilizes the flavin m... A-TITLE A protein bodyguard – private security in the defense against oxidation | |
/about/news/erc-grants-2021/ | 22 Apr'21 Two ERC Advanced Grants for research at Vienna BioCenter A-TITLE Two ERC Advanced Grants for research at Vienna BioCenter | |
/about/news/valneva-initiates-... | 21 Apr'21 Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001 A-TITLE Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001 | |
/about/news/keeping-oocytes-fi... | 21 Apr'21 Keeping oocytes fit with Topoisomerase-3 IMG-ALT Single nuclei stained with DAPI (cyan) and recombinase RAD-51 (red). In top-3 mutant RAD-51 foci were much more abundant and coalesced into stretches, which ... A-TITLE Keeping oocytes fit with Topoisomerase-3 | |
/about/news/flowering-rooted-i... | 20 Apr'21 Flowering rooted in embryonic gene-regulation A-TITLE Flowering rooted in embryonic gene-regulation | |
/about/news/from-bench-to-beds... | 15 Apr'21 From Bench to Bedside - Molecular Pathogenesis to Precision Medicine A-TITLE From Bench to Bedside - Molecular Pathogenesis to Precision Medicine | |
/about/news/valneva-completes-... | 12 Apr'21 Valneva Completes Recruitment for Pivotal Phase 3 Trial of Chikungunya Vaccine Candidate and Initiates Antibody Persistence Trial A-TITLE Valneva Completes Recruitment for Pivotal Phase 3 Trial of Chikungunya Vaccine Candidate and Initiates Antibody Persistence Trial | |
/about/news/brain-organoids-un... | 09 Apr'21 Brain organoids uncover various mechanisms of virus-induced microcephaly A-TITLE Brain organoids uncover various mechanisms of virus-induced microcephaly | |
/about/news/lockdown-for-genom... | 08 Apr'21 Lockdown for genome parasites A-TITLE Lockdown for genome parasites | |
/about/news/valneva-reports-po... | 06 Apr'21 Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001 A-TITLE Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001 | |
/about/news/no-centrioles-no-p... | 01 Apr'21 No centrioles? No problem! IMG-ALT The centrosome scaffolding protein forms foci at the ciliary base of sensory neurons in the head and tail of the nematode worm C. elegans. Unlike centrosomes... A-TITLE No centrioles? No problem! | |
/about/news/tiny-droplets-huge... | 30 Mar'21 Tiny droplets – huge impact: FWF doc.funds grant on liquid-liquid phase separation IMG-ALT Intrinsically disordered protein FATZ-1 phase separates and forms macromolecular condensates with the major sarcomeric Z-disc protein alpha-actinin-2. (c) An... A-TITLE Tiny droplets – huge impact: FWF doc.funds grant on liquid-liquid phase separation | |
/about/news/hidden-in-plain-si... | 16 Mar'21 Hidden in plain sight: A-type lamins in the nucleus IMG-ALT Insoluble and stable higher-order lamin A/C structures in the nuclear interior of LAP2alpha KO cells revealed by super resolution immunofluorescence microsco... A-TITLE Hidden in plain sight: A-type lamins in the nucleus | |
/about/news/when-synthetic-evo... | 12 Mar'21 When synthetic evolution rhymes with natural diversity A-TITLE When synthetic evolution rhymes with natural diversity | |
/about/news/living-in-a-gated-... | 09 Mar'21 Living in a gated community – how stem cells preserve their identity IMG-ALT Snapshot of a t-sne plot showing all genes differentially expressed between ES cells and cells 24 hours after the onset of differentiation. Red dots indicate... A-TITLE Living in a gated community – how stem cells preserve their identity | |
/about/news/valneva-and-pfizer... | 08 Mar'21 Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate A-TITLE Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate | |
/about/news/valneva-reports-fy... | 25 Feb'21 Valneva Reports FY 2020 Results and Major Corporate Achievements A-TITLE Valneva Reports FY 2020 Results and Major Corporate Achievements | |
/about/news/valneva-initiates-... | 22 Feb'21 Valneva Initiates Phase 3 Clinical Lot Consistency Study for its Single-Shot Chikungunya Vaccine Candidate A-TITLE Valneva Initiates Phase 3 Clinical Lot Consistency Study for its Single-Shot Chikungunya Vaccine Candidate | |
/about/news/tearing-down-walls... | 16 Feb'21 Tearing down walls for a new beginning A-TITLE Tearing down walls for a new beginning | |
/about/news/silencing-by-cross... | 11 Feb'21 Silencing by crosstalk A-TITLE Silencing by crosstalk | |
/about/news/shedding-new-light... | 08 Feb'21 Shedding new light on an old problem IMG-ALT STED nanoscopy reveals substructures of the synaptonemal complex. A-TITLE Shedding new light on an old problem | |
/about/news/basic-research-and... | 05 Feb'21 “Basic research and teaching should go hand-in-hand” A-TITLE “Basic research and teaching should go hand-in-hand” | |
/about/news/valneva-announces-... | 01 Feb'21 Valneva Announces UK Government Exercise of Option for 40 Million Doses of its Inactivated, Adjuvanted COVID-19 Vaccine A-TITLE Valneva Announces UK Government Exercise of Option for 40 Million Doses of its Inactivated, Adjuvanted COVID-19 Vaccine | |
/about/news/valneva-commences-... | 28 Jan'21 Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment A-TITLE Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment | |
/about/news/biolution-proudly-... | 26 Jan'21 Biolution proudly presents its new demo reel A-TITLE Biolution proudly presents its new demo reel | |
/about/news/valneva-and-instit... | 25 Jan'21 Valneva and Instituto Butantan Sign Final Agreement on Single-Shot Chikungunya Vaccine for Low and Middle Income Countries A-TITLE Valneva and Instituto Butantan Sign Final Agreement on Single-Shot Chikungunya Vaccine for Low and Middle Income Countries | |
/about/news/strength-in-number... | 21 Jan'21 Strength in numbers: how weak enhancers can be powerful gene regulators IMG-ALT mRNA expression of Fgf5 (red) and Otx2 (yellow) in mouse EpiLCs. (c) Christa Buecker, Max Perutz Labs A-TITLE Strength in numbers: how weak enhancers can be powerful gene regulators | |
/about/news/revealing-the-gene... | 15 Jan'21 Revealing the genetic code of ribosomal RNAs IMG-ALT The schematic cartoon shows rDNA genes, containing single nucleotide variations within the coding (yellow dot) and non-coding regions (orange dot), being tra... A-TITLE Revealing the genetic code of ribosomal RNAs | |
/about/news/valneva-in-advance... | 12 Jan'21 Valneva in Advanced Discussions with European Commission to Supply up to 60 Million Doses of Inactivated, Adjuvanted COVID-19 Vaccine Candidate A-TITLE Valneva in Advanced Discussions with European Commission to Supply up to 60 Million Doses of Inactivated, Adjuvanted COVID-19 Vaccine Candidate | |
/about/news/more-than-just-a-s... | 11 Jan'21 More than just a sun tan: ultraviolet light helps marine animals to tell the time of year A-TITLE More than just a sun tan: ultraviolet light helps marine animals to tell the time of year | |
/about/news/valneva-strengthen... | 11 Jan'21 Valneva Strengthens Management Team; Appoints Perry Celentano as Interim COO and David Lawrence as Acting CFO A-TITLE Valneva Strengthens Management Team; Appoints Perry Celentano as Interim COO and David Lawrence as Acting CFO | |
/about/news/selfish-elements-t... | 07 Jan'21 Selfish elements turn embryos into a battlefield A-TITLE Selfish elements turn embryos into a battlefield | |
/about/news/valneva-reports-fy... | 07 Jan'21 Valneva Reports FY 2020 Cash of Over €200 Million A-TITLE Valneva Reports FY 2020 Cash of Over €200 Million | |
/about/news/smich-doctoral-pro... | 22 Dec'20 SMICH Doctoral Program receives funding by FWF A-TITLE SMICH Doctoral Program receives funding by FWF | |
/about/news/valneva-initiates-... | 16 Dec'20 Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate A-TITLE Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate | |
/about/news/imba-group-leader-... | 10 Dec'20 IMBA Group Leader Nicolas Rivron secures prestigious ERC Grant A-TITLE IMBA Group Leader Nicolas Rivron secures prestigious ERC Grant | |
/about/news/exploring-the-mole... | 09 Dec'20 Exploring the molecular basis of heredity: ERC grant for Joao Matos A-TITLE Exploring the molecular basis of heredity: ERC grant for Joao Matos | |
/about/news/leading-supercompu... | 01 Dec'20 Leading supercomputer cluster starts operations at Vienna BioCenter A-TITLE Leading supercomputer cluster starts operations at Vienna BioCenter | |
/about/news/valneva-announces-... | 10 Nov'20 Valneva Announces Plans for Extraordinary General Meeting to Prepare for Potential US IPO A-TITLE Valneva Announces Plans for Extraordinary General Meeting to Prepare for Potential US IPO | |
/about/news/the-testing-techno... | 05 Nov'20 The testing technology of the future: 36,000 samples in one night A-TITLE The testing technology of the future: 36,000 samples in one night | |
/about/news/valneva-reports-ni... | 03 Nov'20 Valneva Reports Nine Month Results Marked by Further Major Corporate Achievements A-TITLE Valneva Reports Nine Month Results Marked by Further Major Corporate Achievements | |
/about/news/a-groundbreaking-g... | 29 Oct'20 A groundbreaking genetic screening tool for human organoids A-TITLE A groundbreaking genetic screening tool for human organoids | |
/about/news/rt-lamp/ | 21 Oct'20 PCR alternative: RT-LAMP, a new SARS-CoV-2 test "Made in Vienna" IMG-ALT RT-LAMP A-TITLE PCR alternative: RT-LAMP, a new SARS-CoV-2 test "Made in Vienna" | |
/about/news/valnevas-chikungun... | 15 Oct'20 Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation A-TITLE Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation | |
/about/news/no-service-how-vac... | 09 Oct'20 “No service!” How vaccinia virus jams immune signaling A-TITLE “No service!” How vaccinia virus jams immune signaling | |
/about/news/congratulations-to... | 07 Oct'20 Congratulations to Emmanuelle Charpentier on the Nobel Prize for Chemistry A-TITLE Congratulations to Emmanuelle Charpentier on the Nobel Prize for Chemistry | |
/about/news/opgen-group-compan... | 06 Oct'20 OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud A-TITLE OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud | |
/about/news/what-is-the-origin... | 01 Oct'20 What is the origin of the genetic code? A-TITLE What is the origin of the genetic code? | |
/about/news/unraveling-the-gen... | 23 Sep'20 Unraveling the genome in 3D-space A-TITLE Unraveling the genome in 3D-space | |
/about/news/vienna-covid-19-de... | 21 Sep'20 Vienna Covid-19 Detection Initiative (VCDI): a response to Covid-19 from the Vienna BioCenter A-TITLE Vienna Covid-19 Detection Initiative (VCDI): a response to Covid-19 from the Vienna BioCenter | |
/about/news/valneva-announces-... | 18 Sep'20 Valneva Announces Retirement of Chief Financial Officer David Lawrence A-TITLE Valneva Announces Retirement of Chief Financial Officer David Lawrence | |
/about/news/investigating-park... | 18 Sep'20 Investigating Parkinson’s through the lens of autophagy - ASAP grant for Sascha Martens A-TITLE Investigating Parkinson’s through the lens of autophagy - ASAP grant for Sascha Martens | |
/about/news/the-wnt-pathway-ge... | 15 Sep'20 The Wnt pathway gets even more complicated A-TITLE The Wnt pathway gets even more complicated | |
/about/news/valneva-announces-... | 14 Sep'20 Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government A-TITLE Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government | |
/about/news/city-of-vienna-hon... | 09 Sep'20 City of Vienna honours Meinrad Busslinger A-TITLE City of Vienna honours Meinrad Busslinger | |
/about/news/valneva-announces-... | 09 Sep'20 Valneva Announces New IXIARO® Supply Contract with the US Government worth up to $166 million A-TITLE Valneva Announces New IXIARO® Supply Contract with the US Government worth up to $166 million | |
/about/news/valneva-initiates-... | 08 Sep'20 Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553 A-TITLE Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553 | |
/about/news/imba-is-lead-parti... | 07 Sep'20 IMBA is lead participant in a new, cell-based medicine initiative for Europe A-TITLE IMBA is lead participant in a new, cell-based medicine initiative for Europe | |
/about/news/evomet-a-project-t... | 04 Sep'20 Evomet – a project to train future leaders in metastasis research A-TITLE Evomet – a project to train future leaders in metastasis research | |
/about/news/autophagy-the-begi... | 04 Sep'20 Autophagy: the beginning of the end A-TITLE Autophagy: the beginning of the end | |
/about/news/erc-starting-grant... | 03 Sep'20 ERC Starting Grant awarded to Clemens Plaschka of IMP A-TITLE ERC Starting Grant awarded to Clemens Plaschka of IMP | |
/about/news/cell-division-clea... | 02 Sep'20 Cell division: cleaning the nucleus without detergents A-TITLE Cell division: cleaning the nucleus without detergents | |
/about/news/calcium-causes-sti... | 26 Aug'20 Calcium causes stiff joints in ɑ-actinin IMG-ALT 3D-print of the molecular structure of calcium regulated E. histolytica α-actinin dimer. Calmodulin like domains in blue and violet, actin binding domain in ... A-TITLE Calcium causes stiff joints in ɑ-actinin | |
/about/news/a-step-towards-und... | 12 Aug'20 A step towards understanding how animals detect the Earth's magentic field A-TITLE A step towards understanding how animals detect the Earth's magentic field | |
/about/news/valneva-reports-h1... | 04 Aug'20 Valneva Reports H1 Results Marked by Major Corporate Achievements and Strong Cash Position A-TITLE Valneva Reports H1 Results Marked by Major Corporate Achievements and Strong Cash Position | |
/about/news/detective-work-in-... | 31 Jul'20 Detective work in the cell: Scientists uncover a new RNA-modifying enzyme A-TITLE Detective work in the cell: Scientists uncover a new RNA-modifying enzyme | |
/about/news/startup-labs-at-th... | 30 Jul'20 Startup Labs at the Vienna BioCenter open their doors A-TITLE Startup Labs at the Vienna BioCenter open their doors | |
/about/news/catch-a-molecular-... | 29 Jul'20 CaTCH - a molecular time machine for cells A-TITLE CaTCH - a molecular time machine for cells | |
/about/news/cancer-research-vi... | 21 Jul'20 Cancer research: Vienna BioCenter start-up breaks new ground in drug discovery A-TITLE Cancer research: Vienna BioCenter start-up breaks new ground in drug discovery | |
/about/news/sascha-martens-ele... | 07 Jul'20 Sascha Martens elected EMBO member: “I’m looking forward to helping support young scientists” A-TITLE Sascha Martens elected EMBO member: “I’m looking forward to helping support young scientists” | |
/about/news/how-the-immune-sys... | 02 Jul'20 How the immune system generates a vast antibody repertoire to fight infections A-TITLE How the immune system generates a vast antibody repertoire to fight infections | |
/about/news/cep97-a-stabilizin... | 29 Jun'20 Cep97: a stabilizing protein roof for centrioles A-TITLE Cep97: a stabilizing protein roof for centrioles | |
/about/news/researchers-develo... | 24 Jun'20 Researchers develop a "quick and easy" Covid-19 test for population screening with simple means A-TITLE Researchers develop a "quick and easy" Covid-19 test for population screening with simple means | |
/about/news/valneva-and-bavari... | 18 Jun'20 Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership A-TITLE Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership | |
/about/news/batavia-bioscience... | 15 Jun'20 Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine A-TITLE Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine | |
/about/news/valneva-announces-... | 09 Jun'20 Valneva announces HSR clearance for Lyme vaccine collaboration with Pfizer A-TITLE Valneva announces HSR clearance for Lyme vaccine collaboration with Pfizer | |
/about/news/valneva-announces-... | 03 Jun'20 Valneva Announces Publication in The Lancet of Complete Phase 1 Data for its Single-Shot Chikungunya Vaccine Candidate A-TITLE Valneva Announces Publication in The Lancet of Complete Phase 1 Data for its Single-Shot Chikungunya Vaccine Candidate | |
/about/news/a-deep-clear-view-... | 02 Jun'20 A “DEEP-Clear” view of nervous system diversity A-TITLE A “DEEP-Clear” view of nervous system diversity | |
/about/news/happy-virtual-birt... | 29 May'20 Happy - virtual - birthday, Max Perutz! A-TITLE Happy - virtual - birthday, Max Perutz! | |
/about/news/juergen-knoblich-n... | 25 May'20 Jürgen Knoblich now in ISSCR Board of Directors A-TITLE Jürgen Knoblich now in ISSCR Board of Directors | |
/about/news/reverse-engineerin... | 22 May'20 “Reverse engineering” autophagosome biogenesis reveals new protein interactions A-TITLE “Reverse engineering” autophagosome biogenesis reveals new protein interactions | |
/about/news/scientists-discove... | 21 May'20 Scientists discover a gene to stay thin A-TITLE Scientists discover a gene to stay thin | |
/about/news/imp-birnstiel-foun... | 14 May'20 IMP & Birnstiel Foundation open call for 2020 Birnstiel Award A-TITLE IMP & Birnstiel Foundation open call for 2020 Birnstiel Award | |
/about/news/how-plants-forget-... | 11 May'20 How plants forget - new work uncovers how epigenetic marks are specifically reset in sperm A-TITLE How plants forget - new work uncovers how epigenetic marks are specifically reset in sperm | |
/about/news/valneva-reports-q1... | 07 May'20 Valneva Reports Q1 Results and Updates 2020 Guidance Following Major Lyme Partnering Deal A-TITLE Valneva Reports Q1 Results and Updates 2020 Guidance Following Major Lyme Partnering Deal | |
/about/news/valneva-to-partner... | 06 May'20 Valneva to Partner with Instituto Butantan on Single-Shot Chikungunya Vaccine for Low- and Middle- Income Countries A-TITLE Valneva to Partner with Instituto Butantan on Single-Shot Chikungunya Vaccine for Low- and Middle- Income Countries | |
/about/news/valneva-and-pfizer... | 30 Apr'20 Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15 A-TITLE Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15 | |
/about/news/valneva-and-dynava... | 22 Apr'20 Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19 A-TITLE Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19 | |
/about/news/http//wwwcebinaeu/... | 17 Apr'20 CEBINA joins the global efforts to fight COVID-19 A-TITLE CEBINA joins the global efforts to fight COVID-19 | |
/about/news/fighting-sars-cov-... | 03 Apr'20 Fighting SARS-CoV-2 in human blood vessel organoids A-TITLE Fighting SARS-CoV-2 in human blood vessel organoids | |
/about/news/alwin-koehler-appo... | 03 Apr'20 Alwin Köhler appointed as Scientific Director A-TITLE Alwin Köhler appointed as Scientific Director | |
/about/news/valneva-reports-po... | 25 Mar'20 Valneva Reports Positive End-of-Phase 2 Chikungunya Meeting with the U.S. FDA; Sets Stage for Phase 3 Study A-TITLE Valneva Reports Positive End-of-Phase 2 Chikungunya Meeting with the U.S. FDA; Sets Stage for Phase 3 Study | |
/about/news/valneva-provides-b... | 24 Mar'20 Valneva Provides Business Update on COVID-19 Situation A-TITLE Valneva Provides Business Update on COVID-19 Situation | |
/about/news/layered-liquids-re... | 11 Mar'20 Layered Liquids – reaction chambers for gene regulation A-TITLE Layered Liquids – reaction chambers for gene regulation | |
/about/news/valneva-announces-... | 08 Mar'20 Valneva Announces FDA Approval of IXIARO® Shelf Life Extension to 36 Months; New US Military RFP Issued A-TITLE Valneva Announces FDA Approval of IXIARO® Shelf Life Extension to 36 Months; New US Military RFP Issued | |
/about/news/7th-ubiquitin-symp... | 05 Mar'20 7th Ubiquitin Symposium at the Vienna BioCenter A-TITLE 7th Ubiquitin Symposium at the Vienna BioCenter | |
/about/news/httpswwwcalyxhacom... | 04 Mar'20 CALYXHA endeavors to develop novel approaches to tissue degenerative diseases and receives support from Austrian VC and international investors A-TITLE CALYXHA endeavors to develop novel approaches to tissue degenerative diseases and receives support from Austrian VC and international investors | |
/about/news/mechanism-of-inact... | 03 Mar'20 Mechanism of inactivation of the tumor suppressor PP2A: an illusion shattered by reality A-TITLE Mechanism of inactivation of the tumor suppressor PP2A: an illusion shattered by reality | |
/about/news/anete-romanauska-w... | 03 Mar'20 VBC PhD student Anete Romanauska wins Harold M. Weintraub Graduate Student Award A-TITLE VBC PhD student Anete Romanauska wins Harold M. Weintraub Graduate Student Award | |
/about/news/valneva-reports-re... | 27 Feb'20 Valneva Reports Record Product Sales and Major Pipeline Progress in 2019 A-TITLE Valneva Reports Record Product Sales and Major Pipeline Progress in 2019 | |
/about/news/fungal-pathogens-t... | 19 Feb'20 Fungal pathogens tap human iron stores to survive immunity A-TITLE Fungal pathogens tap human iron stores to survive immunity | |
/about/news/how-bacteria-sense... | 18 Feb'20 How bacteria sense and adjust cell envelope precursors A-TITLE How bacteria sense and adjust cell envelope precursors | |
/about/news/women-in-science-2... | 18 Feb'20 FEBS | EMBO Women in Science Award 2020 for IMP's Elly Tanaka A-TITLE FEBS | EMBO Women in Science Award 2020 for IMP's Elly Tanaka | |
/about/news/aelian-wins-vienna... | 12 Feb'20 Aelian Wins Vienna 5G Use Case Challenge A-TITLE Aelian Wins Vienna 5G Use Case Challenge | |
/about/news/toxphacts-availabl... | 04 Feb'20 ToxPHACTS available for purchase A-TITLE ToxPHACTS available for purchase | |
/about/news/valneva-announces-... | 03 Feb'20 Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed A-TITLE Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed | |
/about/news/curetis-company-ar... | 30 Jan'20 Curetis Company Ares Genetics and BGI Group to Offer Sequencing and PCRbased Coronavirus (2019-nCoV) Testing in Europe A-TITLE Curetis Company Ares Genetics and BGI Group to Offer Sequencing and PCRbased Coronavirus (2019-nCoV) Testing in Europe | |
/about/news/calibrating-the-to... | 28 Jan'20 Synanceiidae or Stonefish, elude perception by camouflaging as rocks on the ocean floor. Similarly biological phenomena sometimes elude the percept... A-TITLE Calibrating the tools of life scientists: Antibodies | |
/about/news/affiris-announces-... | 24 Jan'20 AFFiRiS announces Phase 2 study in Parkinson's and new focus on neurodegenerative diseases A-TITLE AFFiRiS announces Phase 2 study in Parkinson's and new focus on neurodegenerative diseases | |
/about/news/phenaris-launches-... | 21 Jan'20 Phenaris launches Transporter Models A-TITLE Phenaris launches Transporter Models | |
/about/news/how-decisions-unfo... | 17 Jan'20 How decisions unfold in a zebrafish brain IMG-ALT Zebrafish A-TITLE How decisions unfold in a zebrafish brain | |
/about/news/valneva-us-dod-exe... | 14 Jan'20 Valneva: US DoD Exercises Option on IXIARO® Supply Contract Bringing Total Value to $70 Million A-TITLE Valneva: US DoD Exercises Option on IXIARO® Supply Contract Bringing Total Value to $70 Million | |
/about/news/valneva-expands-it... | 09 Jan'20 Valneva Expands its Commercial Operations with the Opening of its French Commercial Office A-TITLE Valneva Expands its Commercial Operations with the Opening of its French Commercial Office | |
/about/news/valneva-announces-... | 08 Jan'20 Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate A-TITLE Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate | |
/about/news/valneva-completes-... | 20 Dec'19 Valneva Completes Delisting from the Vienna Stock Exchange A-TITLE Valneva Completes Delisting from the Vienna Stock Exchange | |
/about/news/moonstruck-worms-h... | 17 Dec'19 Moonstruck worms: how lunar cycles affect metabolic decisions A-TITLE Moonstruck worms: how lunar cycles affect metabolic decisions | |
/about/news/valneva-appoints-m... | 16 Dec'19 Valneva Appoints MVM Partner Thomas Casdagli to its Supervisory Board A-TITLE Valneva Appoints MVM Partner Thomas Casdagli to its Supervisory Board | |
/about/news/erc-hattrick-for-i... | 11 Dec'19 “ERC-Hattrick” for IMBA Group leader Stefan Ameres A-TITLE “ERC-Hattrick” for IMBA Group leader Stefan Ameres | |
/about/news/valneva-appoints-r... | 09 Dec'19 Valneva Appoints Renowned Vaccinologists Stanley Plotkin and Anna Durbin to its Scientific Advisory Board A-TITLE Valneva Appoints Renowned Vaccinologists Stanley Plotkin and Anna Durbin to its Scientific Advisory Board | |
/about/news/valneva-to-conduct... | 05 Dec'19 Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference A-TITLE Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference | |
/about/news/special-research-p... | 04 Dec'19 Three Special Research Programme grants for Vienna BioCenter scientists A-TITLE Three Special Research Programme grants for Vienna BioCenter scientists | |
/about/news/a-large-scale-publ... | 03 Dec'19 A large-scale public event bridging science and society IMG-ALT Interdisciplinary panel discussion. ©Paul Pipernig A-TITLE A large-scale public event bridging science and society | |
/about/news/putting-a-lid-on-m... | 28 Nov'19 Putting a Lid on Multidrug Resistance A-TITLE Putting a Lid on Multidrug Resistance | |
/about/news/valneva-announces-... | 28 Nov'19 Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months A-TITLE Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months | |
/about/news/harnessing-the-pow... | 28 Nov'19 Harnessing the power of CRISPR in space and time IMG-ALT CRISPR-Switch. ©IMBA/Kaminski Grafik A-TITLE Harnessing the power of CRISPR in space and time | |
/about/news/httpsuploads-sslwe... | 27 Nov'19 Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize A-TITLE Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize | |
/about/news/imp-researchers-sh... | 22 Nov'19 IMP researchers show that cohesin is a "molecular machine" A-TITLE IMP researchers show that cohesin is a "molecular machine" | |
/about/news/valneva-reports-ex... | 18 Nov'19 Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans A-TITLE Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans | |
/about/news/valneva-announces-... | 14 Nov'19 Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board A-TITLE Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board | |
/about/news/vienna-biocenter-p... | 08 Nov'19 Vienna BioCenter PhD Awards 2019 A-TITLE Vienna BioCenter PhD Awards 2019 | |
/about/news/eveliqures-effort-... | 06 Nov'19 Eveliqure's effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries is supported by the Wellcom... A-TITLE Eveliqure's effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries is supported by the Wellcome Trust | |
/about/news/limits-vs-chances-... | 05 Nov'19 Limits vs. chances of Biotechnology: A public debate A-TITLE Limits vs. chances of Biotechnology: A public debate | |
/about/news/valneva-raises-pro... | 31 Oct'19 Valneva Raises Product Sales Guidance Following Strong Nine-Month Results and R&D Execution A-TITLE Valneva Raises Product Sales Guidance Following Strong Nine-Month Results and R&D Execution | |
/about/news/ares-genetics-laun... | 28 Oct'19 Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test A-TITLE Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test | |
/about/news/essential-biochemi... | 25 Oct'19 Essential biochemical process driven by alternative cellular fuel discovered A-TITLE Essential biochemical process driven by alternative cellular fuel discovered | |
/about/news/a-head-signs-licen... | 25 Oct'19 a:head signs license and collaboration agreements with IMBA and awarded funding from FFG A-TITLE a:head signs license and collaboration agreements with IMBA and awarded funding from FFG | |
/about/news/loreal-austria-wom... | 24 Oct'19 FOR WOMEN IN SCIENCE - IMBA PhD student receives L'Oréal fellowship A-TITLE FOR WOMEN IN SCIENCE - IMBA PhD student receives L'Oréal fellowship | |
/about/news/eveliqures-diarrho... | 23 Oct'19 Eveliqure's diarrhoea vaccine to advance towards clinical trials supported by significant Horizon2020 award. A-TITLE Eveliqure's diarrhoea vaccine to advance towards clinical trials supported by significant Horizon2020 award. | |
/about/news/phagomed-accelerat... | 23 Oct'19 PhagoMed Accelerates R&D Program Against Bacterial Vaginosis. Phage Lysin Stabilizes Vaginal Microbiome. A-TITLE PhagoMed Accelerates R&D Program Against Bacterial Vaginosis. Phage Lysin Stabilizes Vaginal Microbiome. | |
/about/news/four-phd-fellowshi... | 22 Oct'19 Four PhD fellowships for Max Perutz Labs students A-TITLE Four PhD fellowships for Max Perutz Labs students | |
/about/news/vbc-postdoc-sympos... | 16 Oct'19 VBC postdoc symposium on publishing models A-TITLE VBC postdoc symposium on publishing models | |
/about/news/imp-scientists-dis... | 07 Oct'19 IMP scientists discover a mechanism that controls autoimmunity A-TITLE IMP scientists discover a mechanism that controls autoimmunity | |
/about/news/anete-romanauska-i... | 01 Oct'19 Anete Romanauska is Researcher of the Month at the Medical University of Vienna A-TITLE Anete Romanauska is Researcher of the Month at the Medical University of Vienna | |
/about/news/it-takes-two-to-ta... | 26 Sep'19 It takes two to tango: using the ubiquitin fold to turn on secretion A-TITLE It takes two to tango: using the ubiquitin fold to turn on secretion | |
/about/news/novel-catalase-for... | 19 Sep'19 Novel Catalase for complete neutralization of H2O2 in agar plates A-TITLE Novel Catalase for complete neutralization of H2O2 in agar plates | |
/about/news/valneva-confirms-d... | 19 Sep'19 Valneva Confirms Delisting from the Vienna Stock Exchange A-TITLE Valneva Confirms Delisting from the Vienna Stock Exchange | |
/about/news/imp-and-birnstiel-... | 16 Sep'19 IMP and Birnstiel Foundation honour three young scientists with research award A-TITLE IMP and Birnstiel Foundation honour three young scientists with research award | |
/about/news/open-day/ | 16 Sep'19 Campus Open Day: 11 October 2019 A-TITLE Campus Open Day: 11 October 2019 | |
/about/news/erc-funds-to-help-... | 11 Sep'19 ERC funds to help predict drug responses A-TITLE ERC funds to help predict drug responses | |
/about/news/erc-grant-for-inco... | 11 Sep'19 ERC grant for incoming IMP scientist Francisco Balzarotti A-TITLE ERC grant for incoming IMP scientist Francisco Balzarotti | |
/about/news/science-is-never-e... | 03 Sep'19 Why are small RNA so important? A-TITLE Why are small RNA so important? | |
/about/news/fighting-genomic-p... | 21 Aug'19 Fighting genomic parasites – lessons from an unusual organism A-TITLE Fighting genomic parasites – lessons from an unusual organism | |
/about/news/valneva-announces-... | 19 Aug'19 Valneva Announces Management Board Stock Purchases A-TITLE Valneva Announces Management Board Stock Purchases | |
/about/news/ares-genetics-laun... | 08 Aug'19 Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing A-TITLE Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing | |
/about/news/keeping-the-genome... | 08 Aug'19 Keeping the genome in shape: a physiological role for NHEJ in meiosis A-TITLE Keeping the genome in shape: a physiological role for NHEJ in meiosis | |
/about/news/upcycling-of-prote... | 08 Aug'19 Upcycling of proteins protects DNA from parasites A-TITLE Upcycling of proteins protects DNA from parasites | |
/about/news/a-head-launched-to... | 07 Aug'19 a:head - launched to transform CNS drug discovery A-TITLE a:head - launched to transform CNS drug discovery | |
/about/news/science-is-my-life... | 02 Aug'19 "Science is my life" - Interview with Professor Hans Tuppy A-TITLE "Science is my life" - Interview with Professor Hans Tuppy | |
/about/news/valneva-reports-h1... | 01 Aug'19 Valneva Reports H1 2019 Results Marked by Strong Operational Performance and Major Corporate Progress A-TITLE Valneva Reports H1 2019 Results Marked by Strong Operational Performance and Major Corporate Progress | |
/about/news/valneva-announces-... | 29 Jul'19 Valneva Announces Formation of Scientific Advisory Board A-TITLE Valneva Announces Formation of Scientific Advisory Board | |
/about/news/cepi-awards-up-to-... | 25 Jul'19 CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine A-TITLE CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine | |
/about/news/how-does-a-neural-... | 22 Jul'19 How does a neural stem cell know its age? A-TITLE How does a neural stem cell know its age? | |
/about/news/valneva-announces-... | 16 Jul'19 Valneva Announces Drawdown of Further €10 million from its Existing European Investment Bank Loan A-TITLE Valneva Announces Drawdown of Further €10 million from its Existing European Investment Bank Loan | |
/about/news/hookipa-announces-... | 14 Jul'19 HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers A-TITLE HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers | |
/about/news/centrioles-critica... | 12 Jul'19 Centrioles - critical players in cell division A-TITLE Centrioles - critical players in cell division | |
/about/news/ares-genetics-is-g... | 04 Jul'19 Ares Genetics is granted key European patent on genetic resistance testing A-TITLE Ares Genetics is granted key European patent on genetic resistance testing | |
/about/news/valneva-renowned-v... | 03 Jul'19 Valneva: Renowned Vaccinologist Dr. Stanley Plotkin to Present at R&D Investor Day in New York City on July 9th A-TITLE Valneva: Renowned Vaccinologist Dr. Stanley Plotkin to Present at R&D Investor Day in New York City on July 9th | |
/about/news/how-cells-quickly-... | 02 Jul'19 How cells quickly activate innate immunity A-TITLE How cells quickly activate innate immunity | |
/about/news/scarletred-patents... | 02 Jul'19 SCARLETRED: Patents granted in Japan and Australia A-TITLE SCARLETRED: Patents granted in Japan and Australia | |
/about/news/valneva-submits-de... | 02 Jul'19 Valneva Submits Delisting Application to the Vienna Stock Exchange A-TITLE Valneva Submits Delisting Application to the Vienna Stock Exchange | |
/about/news/valneva-initiates-... | 01 Jul'19 Valneva Initiates Second Phase 2 Study for its Lyme Disease Vaccine Candidate VLA15 A-TITLE Valneva Initiates Second Phase 2 Study for its Lyme Disease Vaccine Candidate VLA15 | |
/about/news/phagomed-biopharma... | 01 Jul'19 PhagoMed Biopharma GmbH successfully completed another financing round. A-TITLE PhagoMed Biopharma GmbH successfully completed another financing round. | |
/about/news/valneva-shareholde... | 28 Jun'19 Valneva Shareholders Approve all Resolutions Recommended by the Management Board at the Annual General Meeting A-TITLE Valneva Shareholders Approve all Resolutions Recommended by the Management Board at the Annual General Meeting | |
/about/news/valneva-announces-... | 20 Jun'19 Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D A-TITLE Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D | |
/about/news/new-tool-for-visua... | 17 Jun'19 New tool for visualizing molecule properties developed at the Max Perutz Labs A-TITLE New tool for visualizing molecule properties developed at the Max Perutz Labs | |
/about/news/i-am-excited-by-th... | 13 Jun'19 “I am excited by the idea that we discover the unknown about the most fundamental things in life.” A-TITLE “I am excited by the idea that we discover the unknown about the most fundamental things in life.” | |
/about/news/valneva-to-present... | 12 Jun'19 Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th A-TITLE Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th | |
/about/news/valneva-reports-su... | 12 Jun'19 Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate A-TITLE Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate | |
/about/news/hookipa-pharma-ann... | 10 Jun'19 HOOKIPA Pharma Announces Oral Presentation of HB-101 CMV Vaccine Phase 1 Data at the American Transplant Congress A-TITLE HOOKIPA Pharma Announces Oral Presentation of HB-101 CMV Vaccine Phase 1 Data at the American Transplant Congress | |
/about/news/vienna-biocenter-h... | 06 Jun'19 Vienna BioCenter hosts first EMBO Fellow Mini-Symposium A-TITLE Vienna BioCenter hosts first EMBO Fellow Mini-Symposium | |
/about/news/first-max-perutz-d... | 31 May'19 First Max Perutz Day kicks off a new era at the Max Perutz Labs Vienna A-TITLE First Max Perutz Day kicks off a new era at the Max Perutz Labs Vienna | |
/about/news/embo-workshop-to-d... | 31 May'19 EMBO workshop at the Vienna BioCenter in September to discuss genome organisation by SMC complexes A-TITLE EMBO workshop at the Vienna BioCenter in September to discuss genome organisation by SMC complexes | |
/about/news/new-video-tutorial... | 29 May'19 New video tutorial on how to use SLAMseq for profiling transcriptional responses to drugs A-TITLE New video tutorial on how to use SLAMseq for profiling transcriptional responses to drugs | |
/about/news/phages-take-center... | 23 May'19 Phages take center stage in a new animation by biolution A-TITLE Phages take center stage in a new animation by biolution | |
/about/news/an-amplified-spindle/ | 23 May'19 An amplified spindle A-TITLE An amplified spindle | |
/about/news/valneva-reports-fu... | 22 May'19 Valneva Reports Further Positive Results for Its Chikungunya Vaccine Candidate A-TITLE Valneva Reports Further Positive Results for Its Chikungunya Vaccine Candidate | |
/about/news/first-embo-fellow-... | 17 May'19 First EMBO Fellow symposium at Vienna BioCenter A-TITLE First EMBO Fellow symposium at Vienna BioCenter | |
/about/news/audio-portray-on-d... | 17 May'19 Audio portray on David Haselbach's work on molecular machines A-TITLE Audio portray on David Haselbach's work on molecular machines | |
/about/news/activation-of-gene... | 15 May'19 Activation of gene promoters: Vienna BioCenter scientists discover basis of regulatory specificity A-TITLE Activation of gene promoters: Vienna BioCenter scientists discover basis of regulatory specificity | |
/about/news/hookipa-achieves-r... | 09 May'19 HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead A-TITLE HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead | |
/about/news/valneva-reports-st... | 02 May'19 Valneva Reports Strong Q1 2019 Operating Results and Advances Key R&D Programs towards Major Milestones A-TITLE Valneva Reports Strong Q1 2019 Operating Results and Advances Key R&D Programs towards Major Milestones | |
/about/news/awards-graduate-st... | 02 May'19 Birnstiel Award: international competition of best PhD students A-TITLE Birnstiel Award: international competition of best PhD students | |
/about/news/vienna-biocenter-l... | 16 Apr'19 Vienna BioCenter launches "VIP2": a three-year postdoctoral program. A-TITLE Vienna BioCenter launches "VIP2": a three-year postdoctoral program. | |
/about/news/arabidopsis-immune... | 11 Apr'19 Arabidopsis immune system is triggered by small bacterial fatty acids A-TITLE Arabidopsis immune system is triggered by small bacterial fatty acids | |
/about/news/andreas-bachmair-a... | 09 Apr'19 Andreas Bachmair appointed full professor A-TITLE Andreas Bachmair appointed full professor | |
/about/news/valneva-to-present... | 09 Apr'19 Valneva to Present on Lyme and Chikungunya Vaccine Candidates at the 19th World Vaccine Congress A-TITLE Valneva to Present on Lyme and Chikungunya Vaccine Candidates at the 19th World Vaccine Congress | |
/about/news/a-new-type-of-prot... | 08 Apr'19 A new type of protein phosphorylation characterised A-TITLE A new type of protein phosphorylation characterised | |
/about/news/new-funding-for-st... | 20 Mar'19 New funding for stem cell research at MFPL and the Vienna BioCenter A-TITLE New funding for stem cell research at MFPL and the Vienna BioCenter | |
/about/news/student-open-day/ | 18 Mar'19 Student Open Day A-TITLE Student Open Day | |
/about/news/vbc-phd-programme-... | 04 Mar'19 VBC PhD Programme: Open Call until 15 April 2019 A-TITLE VBC PhD Programme: Open Call until 15 April 2019 | |
/about/news/new-marie-curie-fe... | 04 Mar'19 Four new Marie Curie Fellowships at the Vienna BioCenter A-TITLE Four new Marie Curie Fellowships at the Vienna BioCenter | |
/about/news/hookipa-pharma-rai... | 26 Feb'19 HOOKIPA Pharma Raises $37.4 million (€33.2 million) in Series D Financing A-TITLE HOOKIPA Pharma Raises $37.4 million (€33.2 million) in Series D Financing | |
/about/news/central-dogma-video/ | 21 Feb'19 New animation video explains gene expression in unprecedented detail A-TITLE New animation video explains gene expression in unprecedented detail | |
/about/news/httpswwwvalnevacom... | 21 Feb'19 Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019 A-TITLE Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019 | |
/about/news/ares-genetics-and-... | 19 Feb'19 Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance A-TITLE Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance | |
/about/news/sy-stem-symposium/ | 19 Feb'19 SY-Stem Symposium at the Vienna BioCenter: 21-23 March 2019. A-TITLE SY-Stem Symposium at the Vienna BioCenter: 21-23 March 2019. | |
/about/news/14th-microsymposiu... | 19 Feb'19 14th Microsymposium on Small RNA Biology at the Vienna BioCenter: 15-17 May 2019. A-TITLE 14th Microsymposium on Small RNA Biology at the Vienna BioCenter: 15-17 May 2019. | |
/about/news/hookipa-appoints-m... | 19 Feb'19 HOOKIPA Appoints Michael A. Kelly as Independent Director A-TITLE HOOKIPA Appoints Michael A. Kelly as Independent Director | |
/about/news/ubiquitin-friends-... | 13 Feb'19 Ubiquitin & Friends 2019: symposium in Vienna A-TITLE Ubiquitin & Friends 2019: symposium in Vienna | |
/about/news/audio-portrait-of-... | 06 Feb'19 Audio portrait of IMP Group Leader Clemens Plaschka A-TITLE Audio portrait of IMP Group Leader Clemens Plaschka | |
/about/news/valneva-reports-po... | 31 Jan'19 Valneva Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate A-TITLE Valneva Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate | |
/about/news/imba-at-the-ball-o... | 29 Jan'19 Vienna BioCenter at the ball of sciences A-TITLE Vienna BioCenter at the ball of sciences | |
/about/news/proteomics-facility/ | 22 Jan'19 10 Million Euros for Access to European Proteomics Facilities A-TITLE 10 Million Euros for Access to European Proteomics Facilities | |
/about/news/obituary-andreas-w... | 18 Jan'19 Obituary: Andreas Weith (1953 to 2019), former IMP Group Leader A-TITLE Obituary: Andreas Weith (1953 to 2019), former IMP Group Leader | |
/about/news/valneva-announces-... | 16 Jan'19 Valneva Announces New $59 Million IXIARO® Supply Contract with US Government A-TITLE Valneva Announces New $59 Million IXIARO® Supply Contract with US Government | |
/about/news/valneva-confirms-f... | 16 Jan'19 Valneva Confirms FY 2018 Guidance and Provides Initial Product Sales Revenue Guidance for 2019 A-TITLE Valneva Confirms FY 2018 Guidance and Provides Initial Product Sales Revenue Guidance for 2019 | |
/about/news/valneva-reports-po... | 08 Jan'19 Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate A-TITLE Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate | |
/about/news/ares-genetics-adva... | 08 Jan'19 Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test A-TITLE Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test | |
/about/news/valneva-announces-... | 08 Jan'19 Valneva Announces its Intention to Delist from the Vienna Stock Exchange A-TITLE Valneva Announces its Intention to Delist from the Vienna Stock Exchange | |
/about/news/hookipa-achieves-f... | 03 Jan'19 HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead A-TITLE HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead | |
/about/news/valneva-awarded-fd... | 03 Jan'19 Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate A-TITLE Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate | |
/about/news/vbc-summer-school-... | 18 Dec'18 VBC Summer School 2019 application deadline: 31 January 2019 A-TITLE VBC Summer School 2019 application deadline: 31 January 2019 | |
/about/news/ares-genetics-team... | 18 Dec'18 Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance A-TITLE Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance | |
/about/news/valneva-initiates-... | 17 Dec'18 Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate A-TITLE Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate | |
/about/news/httpswwwhookipapha... | 17 Dec'18 HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus A-TITLE HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus | |
/about/news/ | See all news | |
/vbcf/ | Trivial anchor text Read More | |
/companies/biotech-companies/a... | New window Text duplicate | Link to Page |
/companies/biotech-companies/a... | New window Text duplicate | Link to Page |
/companies/biotech-companies/a... | New window Text duplicate | Link to Page |
/companies/biotech-companies/a... | New window Text duplicate | Link to Page IMG-ALT AFFiRiS |
/companies/biotech-companies/a... | New window Text duplicate | Link to Page IMG-ALT Akribes |
/companies/biotech-companies/a... | New window Text duplicate | Link to Page IMG-ALT Austrianni |
/companies/service-companies/b... | New window Text duplicate | Link to Page IMG-ALT Biolution |
/companies/biotech-companies/b... | New window Text duplicate | Link to Page |
/companies/biotech-companies/b... | New window Text duplicate | Link to Page |
/companies/biotech-companies/b... | New window Text duplicate | Link to Page |
/companies/biotech-companies/b... | New window Text duplicate | Link to Page |
/companies/biotech-companies/c... | New window Text duplicate | Link to Page |
/companies/business-incubators... | New window Text duplicate | Link to Page |
/companies/biotech-companies/c... | New window Text duplicate | Link to Page IMG-ALT ChanPharm |
/companies/biotech-companies/e... | New window Text duplicate | Link to Page |
/companies/biotech-companies/e... | New window Text duplicate | Link to Page |
/companies/biotech-companies/e... | New window Text duplicate | Link to Page |
/about/vbc-at-a-glance/who-is-... | New window Text duplicate | Link to Page IMG-ALT GMI |
/companies/biotech-companies/g... | New window Subdomain Text duplicate | Link to Page |
/companies/biotech-companies/h... | New window Text duplicate | Link to Page IMG-ALT Hookipa |
/about/vbc-at-a-glance/who-is-... | New window Text duplicate | Link to Page IMG-ALT IMBA |
/about/vbc-at-a-glance/who-is-... | New window Text duplicate | Link to Page IMG-ALT IMP |
/companies/business-incubators... | New window Text duplicate | Link to Page |
/companies/biotech-companies/i... | New window Text duplicate | Link to Page |
/companies/biotech-companies/j... | New window Text duplicate | Link to Page |
/companies/service-companies/l... | New window Text duplicate | Link to Page IMG-ALT LabConsulting |
/companies/biotech-companies/l... | New window Text duplicate | Link to Page |
/about/vbc-at-a-glance/who-is-... | New window Subdomain Text duplicate | Link to Page |
/companies/biotech-companies/m... | New window Text duplicate | Link to Page IMG-ALT Miti-Biosystems |
/companies/biotech-companies/m... | New window Text duplicate | Link to Page |
/companies/biotech-companies/m... | New window Text duplicate | Link to Page |
/companies/service-companies/n... | New window Text duplicate | Link to Page IMG-ALT N4B |
/about/vbc-at-a-glance/who-is-... | New window Text duplicate | Link to Page IMG-ALT OEGMBT |
/companies/biotech-companies/o... | New window Text duplicate | Link to Page |
/about/vbc-at-a-glance/who-is-... | New window Text duplicate | Link to Page IMG-ALT Open Science |
/companies/biotech-companies/p... | New window Text duplicate | Link to Page |
/companies/biotech-companies/p... | New window Text duplicate | Link to Page |
/companies/biotech-companies/q... | New window Text duplicate | Link to Page |
/companies/biotech-companies/s... | New window Text duplicate | Link to Page |
/companies/biotech-companies/t... | New window Text duplicate | Link to Page |
/companies/biotech-companies/t... | New window Text duplicate | Link to Page IMG-ALT Thermo Fisher |
/companies/biotech-companies/t... | New window Text duplicate | Link to Page |
/companies/tridem-bioscience/ | New window Text duplicate | Link to Page |
/about/vbc-at-a-glance/who-is-... | New window Text duplicate | Link to Page |
/about/vbc-at-a-glance/who-is-... | New window Text duplicate | Link to Page |
/companies/biotech-companies/v... | New window Text duplicate | Link to Page IMG-ALT Valneva |
/about/vbc-at-a-glance/who-is-... | New window Text duplicate | Link to Page IMG-ALT Vienna Open Lab |
/vbcf/ | New window Text duplicate | Link to Page IMG-ALT VBCF |
/companies/biotech-companies/x... | New window Text duplicate | Link to Page |
https://twitter.com/viennabioc... | External | A-TITLE twitter |
https://www.youtube.com/channe... | External Subdomain | A-TITLE youtube |
https://www.linkedin.com/compa... | External Subdomain | A-TITLE linkedIn |
/about/news/ | Text duplicate | News A-TITLE News |
/research/research-groups/ | Text duplicate | Research Groups A-TITLE Research Groups |
/about/events/ | Events A-TITLE Events | |
/companies/biotech-companies/ | Text duplicate | Biotech Companies A-TITLE Biotech Companies |
/about/downloads/ | Text duplicate | Downloads A-TITLE Downloads |
/career/open-positions/ | Text duplicate | Job Offers A-TITLE Job Offers |
https://drive.google.com/file/... | External Subdomain | Cafeteria Menu A-TITLE Cafeteria Menu |
/about/contact/ | Text duplicate | Contact A-TITLE Contact |
/legal-notice-imprint/ | Legal Notice & Imprint | |
/legal-notice-imprint/ | Learn More |
Name | Value |
---|---|
content-language | en-US |
cache-control | private, no-store |
vary | Topwire-Context,Accept-Encoding,User-Agent |
referrer-policy | no-referrer-when-downgrade |
expires | Sat, 22 Jun 2024 01:41:54 GMT |
content-encoding | gzip |
strict-transport-security | max-age=15768000; |
x-frame-options | SAMEORIGIN |
x-xss-protection | 1; mode=block |
x-ua-compatible | IE=edge |
x-content-type-options | nosniff |
content-type | text/html; charset=utf-8 |
date | Sat, 22 Jun 2024 01:41:54 GMT |
server | Apache |
statuscode | 200 |
http_version | HTTP/2 |
User-Agent: * Allow: / # TYPO3 Disallow: /typo3/ # TYPO3 Conf Disallow: /typo3conf/ Allow: /typo3conf/ext/*/Public/* # TYPO3 Fileadmin Temp Disallow: /fileadmin/_temp_/ # TYPO3 Temp Disallow: /typo3temp/ Allow: /typo3temp/GB/ Allow: /typo3temp/pics/ Allow: /typo3temp/assets/_processed_/* Allow: /typo3temp/assets/compressed/merged*.css* Allow: /typo3temp/assets/compressed/merged*.css.gzip* Allow: /typo3temp/assets/compressed/merged*.js* Allow: /typo3temp/assets/compressed/merged*.js.gzip* # Parameters Disallow: /*?id=* Disallow: /*cHash Disallow: /*tx_form_formframework Disallow: /*tx_powermail # Allow Sitemaps with cHash Allow: /sitemap.xml?sitemap=*&cHash=* Allow: /sitemap.xml?page=*&sitemap=*&cHash=* # Sitemap Sitemap: https://www.viennabiocenter.org/sitemap.xml
Following keywords were found. You can check the keyword optimization of this page for each keyword.
Keyword | Result | Recheck |
---|---|---|
Vienna | 83% | Check |
Vienna BioCenter | 81% | Check |
BioCenter | 79% | Check |
Research Vienna BioCenter | 73% | Check |
Life Science | 72% | Check |
Life | 70% | Check |
Science | 70% | Check |
Vienna BioCenter PhD | 70% | Check |
Vienna BioCenter Scientists | 69% | Check |
visits Vienna BioCenter | 68% | Check |
Life Science Cluster | 66% | Check |
Labs Vienna | 66% | Check |
Vienna BioCenter PhD Symposium | 65% | Check |
Vienna BioCenter PhD Awards | 64% | Check |
Life Sciences | 63% | Check |
LEADING LIFE | 63% | Check |
Leading life science cluster | 63% | Check |
Research | 58% | Check |
leader | 58% | Check |
US Government | 58% | Check |
life scientists | 57% | Check |
Sciences | 56% | Check |
Max Perutz Labs Vienna | 56% | Check |
Vienna Stock Exchange | 56% | Check |
LEADING | 54% | Check |
Please select one of the following options for your request.
Contact options
Send us an email at [email protected]
Give us a call +49 911 23756261
Mo-Fr (CET)
from 9 am to 5 pm
None of these options suit your need?
You can also download our Quick Start Guide, visit the FAQ section, our Knowledge Base or Blog.
Please select one of the following options for your request.
We have received your message and will process it as soon as possible.
We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.
We need these so the site can function properly
So we can better understand how visitors use our website
So we can serve you tailored ads and promotions
(Nice to have)